0000866291 FALSE 2023 Q1 3/31 0000866291 2022-03-26 2022-06-24 0000866291 2022-07-22 xbrli:shares 0000866291 2022-06-24 iso4217:USD 0000866291 2022-03-25 iso4217:USD xbrli:shares 0000866291 algm:NonRelatedPartyMember 2022-03-26 2022-06-24 0000866291 algm:NonRelatedPartyMember 2021-03-27 2021-06-25 0000866291 algm:RelatedPartyMember 2022-03-26 2022-06-24 0000866291 algm:RelatedPartyMember 2021-03-27 2021-06-25 0000866291 2021-03-27 2021-06-25 0000866291 us-gaap:CommonStockMember 2021-03-26 0000866291 us-gaap:AdditionalPaidInCapitalMember 2021-03-26 0000866291 us-gaap:RetainedEarningsMember 2021-03-26 0000866291 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-26 0000866291 us-gaap:NoncontrollingInterestMember 2021-03-26 0000866291 2021-03-26 0000866291 us-gaap:RetainedEarningsMember 2021-03-27 2021-06-25 0000866291 us-gaap:NoncontrollingInterestMember 2021-03-27 2021-06-25 0000866291 us-gaap:CommonStockMember 2021-03-27 2021-06-25 0000866291 us-gaap:AdditionalPaidInCapitalMember 2021-03-27 2021-06-25 0000866291 us-gaap:CommonStockMember 2021-06-25 0000866291 us-gaap:AdditionalPaidInCapitalMember 2021-06-25 0000866291 us-gaap:RetainedEarningsMember 2021-06-25 0000866291 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-25 0000866291 us-gaap:NoncontrollingInterestMember 2021-06-25 0000866291 2021-06-25 0000866291 us-gaap:CommonStockMember 2022-03-25 0000866291 us-gaap:AdditionalPaidInCapitalMember 2022-03-25 0000866291 us-gaap:RetainedEarningsMember 2022-03-25 0000866291 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-25 0000866291 us-gaap:NoncontrollingInterestMember 2022-03-25 0000866291 us-gaap:RetainedEarningsMember 2022-03-26 2022-06-24 0000866291 us-gaap:NoncontrollingInterestMember 2022-03-26 2022-06-24 0000866291 us-gaap:CommonStockMember 2022-03-26 2022-06-24 0000866291 us-gaap:AdditionalPaidInCapitalMember 2022-03-26 2022-06-24 0000866291 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-26 2022-06-24 0000866291 us-gaap:CommonStockMember 2022-06-24 0000866291 us-gaap:AdditionalPaidInCapitalMember 2022-06-24 0000866291 us-gaap:RetainedEarningsMember 2022-06-24 0000866291 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-24 0000866291 us-gaap:NoncontrollingInterestMember 2022-06-24 0000866291 us-gaap:TradeAccountsReceivableMember us-gaap:CustomerConcentrationRiskMember algm:SankenMember 2022-03-26 2022-06-24 xbrli:pure 0000866291 us-gaap:TradeAccountsReceivableMember us-gaap:CustomerConcentrationRiskMember algm:SankenMember 2021-03-27 2022-03-25 0000866291 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember algm:SankenMember 2022-03-26 2022-06-24 0000866291 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember algm:SankenMember 2021-03-27 2021-06-25 0000866291 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-03-26 2022-06-24 0000866291 country:CN us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-03-26 2022-06-24 0000866291 country:JP us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2022-03-26 2022-06-24 0000866291 us-gaap:NonUsMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-03-27 2021-06-25 0000866291 country:CN us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-03-27 2021-06-25 0000866291 country:JP us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-03-27 2021-06-25 0000866291 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember country:KR 2021-03-27 2021-06-25 0000866291 algm:AutomotiveEndMarketMember 2022-03-26 2022-06-24 0000866291 algm:AutomotiveEndMarketMember 2021-03-27 2021-06-25 0000866291 algm:IndustrialEndMarketMember 2022-03-26 2022-06-24 0000866291 algm:IndustrialEndMarketMember 2021-03-27 2021-06-25 0000866291 algm:OtherEndMarketMember 2022-03-26 2022-06-24 0000866291 algm:OtherEndMarketMember 2021-03-27 2021-06-25 0000866291 algm:PowerIntegratedCircuitsMember 2022-03-26 2022-06-24 0000866291 algm:PowerIntegratedCircuitsMember 2021-03-27 2021-06-25 0000866291 algm:MagneticSensorsMember 2022-03-26 2022-06-24 0000866291 algm:MagneticSensorsMember 2021-03-27 2021-06-25 0000866291 algm:PhotonicsMember 2022-03-26 2022-06-24 0000866291 algm:PhotonicsMember 2021-03-27 2021-06-25 0000866291 country:US 2022-03-26 2022-06-24 0000866291 country:US 2021-03-27 2021-06-25 0000866291 algm:OtherAmericasMember 2022-03-26 2022-06-24 0000866291 algm:OtherAmericasMember 2021-03-27 2021-06-25 0000866291 srt:EuropeMember 2022-03-26 2022-06-24 0000866291 srt:EuropeMember 2021-03-27 2021-06-25 0000866291 country:JP 2022-03-26 2022-06-24 0000866291 country:JP 2021-03-27 2021-06-25 0000866291 country:CN 2022-03-26 2022-06-24 0000866291 country:CN 2021-03-27 2021-06-25 0000866291 country:KR 2022-03-26 2022-06-24 0000866291 country:KR 2021-03-27 2021-06-25 0000866291 algm:OtherAsiaMember 2022-03-26 2022-06-24 0000866291 algm:OtherAsiaMember 2021-03-27 2021-06-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2022-03-25 0000866291 algm:VoxtelIncMember 2020-08-28 0000866291 algm:VoxtelIncMember 2020-08-28 2020-08-28 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2022-03-26 2022-06-24 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2021-03-26 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2021-03-27 2021-06-25 0000866291 us-gaap:FairValueMeasurementsRecurringMember 2021-06-25 0000866291 us-gaap:LandMember 2022-06-24 0000866291 us-gaap:LandMember 2022-03-25 0000866291 algm:BuildingsBuildingImprovementsAndLeaseholdImprovementsMember 2022-06-24 0000866291 algm:BuildingsBuildingImprovementsAndLeaseholdImprovementsMember 2022-03-25 0000866291 us-gaap:MachineryAndEquipmentMember 2022-06-24 0000866291 us-gaap:MachineryAndEquipmentMember 2022-03-25 0000866291 us-gaap:OfficeEquipmentMember 2022-06-24 0000866291 us-gaap:OfficeEquipmentMember 2022-03-25 0000866291 us-gaap:ConstructionInProgressMember 2022-06-24 0000866291 us-gaap:ConstructionInProgressMember 2022-03-25 0000866291 country:US 2022-06-24 0000866291 country:US 2022-03-25 0000866291 country:PH 2022-06-24 0000866291 country:PH 2022-03-25 0000866291 algm:OtherCountriesMember 2022-06-24 0000866291 algm:OtherCountriesMember 2022-03-25 0000866291 us-gaap:ToolsDiesAndMoldsMember 2022-03-26 2022-06-24 0000866291 us-gaap:ToolsDiesAndMoldsMember 2021-03-27 2021-06-25 0000866291 us-gaap:PatentsMember 2022-06-24 0000866291 us-gaap:PatentsMember 2022-03-26 2022-06-24 0000866291 us-gaap:CustomerRelationshipsMember 2022-06-24 0000866291 us-gaap:CustomerRelationshipsMember 2022-03-26 2022-06-24 0000866291 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-24 0000866291 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-03-26 2022-06-24 0000866291 algm:IndefiniteLivedTechnologyBasedIntangibleAssetsMember 2022-06-24 0000866291 us-gaap:TrademarksMember 2022-06-24 0000866291 us-gaap:TrademarksMember 2022-03-26 2022-06-24 0000866291 algm:LegacyTrademarksMember 2022-06-24 0000866291 us-gaap:OtherIntangibleAssetsMember 2022-06-24 0000866291 us-gaap:PatentsMember 2022-03-25 0000866291 us-gaap:PatentsMember 2021-03-27 2022-03-25 0000866291 us-gaap:CustomerRelationshipsMember 2022-03-25 0000866291 us-gaap:CustomerRelationshipsMember 2021-03-27 2022-03-25 0000866291 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-03-25 0000866291 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-03-27 2022-03-25 0000866291 algm:IndefiniteLivedTechnologyBasedIntangibleAssetsMember 2022-03-25 0000866291 us-gaap:TrademarksMember 2022-03-25 0000866291 us-gaap:TrademarksMember 2021-03-27 2022-03-25 0000866291 algm:LegacyTrademarksMember 2022-03-25 0000866291 us-gaap:OtherIntangibleAssetsMember 2022-03-25 0000866291 algm:TermLoanFacilityMember algm:CreditSuisseAGCaymanIslandsBranchMember 2020-09-30 0000866291 us-gaap:RevolvingCreditFacilityMember algm:MizuhoBankLtdMember 2020-09-30 0000866291 us-gaap:RevolvingCreditFacilityMember algm:MizuhoBankLtdMember 2022-06-24 0000866291 algm:TermLoanFacilityMember us-gaap:LineOfCreditMember 2022-03-25 0000866291 algm:TermLoanFacilityMember us-gaap:LineOfCreditMember 2022-06-24 0000866291 us-gaap:RevolvingCreditFacilityMember algm:MizuhoBankLtdMember 2022-03-25 0000866291 algm:LineOfCreditAgreementExpiringAugust312021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2019-11-26 iso4217:PHP 0000866291 algm:LineOfCreditAgreementExpiringAugust312021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2022-06-24 0000866291 algm:LineOfCreditAgreementExpiringAugust312021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2022-03-25 0000866291 algm:LineOfCreditAgreementExpiringJune302021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2019-11-20 0000866291 algm:LineOfCreditAgreementExpiringJune302021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2022-06-24 0000866291 algm:LineOfCreditAgreementExpiringJune302021Member algm:UnsecuredRevolvingCreditFacilitiesMember us-gaap:LineOfCreditMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember 2021-03-27 2021-06-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-06-24 0000866291 algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member us-gaap:BankLoanObligationsMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-06-24 0000866291 us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USTreasuryAndGovernmentMember 2022-03-25 0000866291 algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member algm:UnitInvestmentTrustFundMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member us-gaap:BankLoanObligationsMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-03-25 0000866291 us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateBondSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:PensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2022-03-26 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2022-06-24 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2021-03-26 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2021-03-26 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2021-03-27 2021-06-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2021-03-27 2021-06-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:BankLoanObligationsMember 2021-06-25 0000866291 us-gaap:FairValueInputsLevel3Member us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember us-gaap:PensionPlansDefinedBenefitMember 2021-06-25 0000866291 algm:PensionPromiseMember us-gaap:OtherPensionPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 algm:PensionPromiseMember us-gaap:OtherPensionPlansDefinedBenefitMember 2022-06-24 iso4217:GBP 0000866291 algm:PensionPromiseMember us-gaap:OtherPensionPlansDefinedBenefitMember 2022-03-25 0000866291 algm:Company401KPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-03-27 2021-06-25 0000866291 algm:AMEPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-03-26 2022-06-24 0000866291 algm:AMEPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-03-27 2021-06-25 0000866291 us-gaap:RestrictedStockUnitsRSUMember 2022-03-26 2022-06-24 0000866291 us-gaap:RestrictedStockUnitsRSUMember 2021-03-27 2021-06-25 0000866291 us-gaap:PerformanceSharesMember 2022-03-26 2022-06-24 0000866291 us-gaap:PerformanceSharesMember 2021-03-27 2021-06-25 0000866291 us-gaap:EmployeeStockMember 2022-03-26 2022-06-24 0000866291 us-gaap:EmployeeStockMember 2021-03-27 2021-06-25 0000866291 us-gaap:RestrictedStockUnitsRSUMember 2022-06-24 0000866291 srt:MinimumMember us-gaap:PerformanceSharesMember 2022-06-24 0000866291 us-gaap:PerformanceSharesMember srt:MaximumMember 2022-06-24 0000866291 us-gaap:PerformanceSharesMember 2022-06-24 0000866291 us-gaap:RestrictedStockMember 2022-03-26 2022-06-24 0000866291 us-gaap:RestrictedStockMember 2021-03-27 2021-06-25 0000866291 us-gaap:RestrictedStockMember 2022-06-24 0000866291 us-gaap:CostOfSalesMember 2022-03-26 2022-06-24 0000866291 us-gaap:CostOfSalesMember 2021-03-27 2021-06-25 0000866291 us-gaap:ResearchAndDevelopmentExpenseMember 2022-03-26 2022-06-24 0000866291 us-gaap:ResearchAndDevelopmentExpenseMember 2021-03-27 2021-06-25 0000866291 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-26 2022-06-24 0000866291 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-03-27 2021-06-25 0000866291 srt:PresidentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-26 2022-06-24 0000866291 algm:SankenMember 2022-06-24 0000866291 algm:RelatedPartyMember us-gaap:MajorityShareholderMember 2022-03-26 2022-06-24 0000866291 algm:RelatedPartyMember us-gaap:MajorityShareholderMember 2021-03-27 2021-06-25 0000866291 us-gaap:MajorityShareholderMember 2022-06-24 0000866291 us-gaap:MajorityShareholderMember 2022-03-25 0000866291 algm:SankenMember algm:PolarSemiconductorLLCMember 2022-06-24 0000866291 algm:AllegroMicrosystemsIncMember algm:PolarSemiconductorLLCMember 2022-06-24 0000866291 us-gaap:EquityMethodInvesteeMember 2022-03-26 2022-06-24 0000866291 us-gaap:EquityMethodInvesteeMember 2021-03-27 2021-06-25 0000866291 us-gaap:EquityMethodInvesteeMember 2022-06-24 0000866291 us-gaap:EquityMethodInvesteeMember 2022-03-25 0000866291 algm:InitialPSLLoanMember us-gaap:EquityMethodInvesteeMember us-gaap:LoansPayableMember 2021-12-02 0000866291 us-gaap:EquityMethodInvesteeMember srt:ScenarioForecastMember algm:SecondaryPSLLoanMember us-gaap:LoansPayableMember 2023-01-01 2023-01-01 0000866291 us-gaap:EquityMethodInvesteeMember srt:ScenarioForecastMember algm:SecondaryPSLLoanMember us-gaap:LoansPayableMember 2023-01-01 0000866291 algm:InitialPSLLoanMember us-gaap:EquityMethodInvesteeMember us-gaap:LoansPayableMember 2022-06-24 0000866291 algm:InitialPSLLoanMember us-gaap:EquityMethodInvesteeMember us-gaap:LoansPayableMember 2022-03-26 2022-06-24 0000866291 algm:InitialPSLLoanMember us-gaap:EquityMethodInvesteeMember us-gaap:LoansPayableMember us-gaap:SubsequentEventMember 2022-07-01 2022-07-01 0000866291 us-gaap:MajorityShareholderMember 2022-03-26 2022-06-24 0000866291 us-gaap:MajorityShareholderMember 2021-03-27 2021-06-25 0000866291 srt:DirectorMember 2021-03-27 2021-06-25 0000866291 srt:DirectorMember 2022-03-26 2022-06-24 0000866291 srt:DirectorMember 2022-03-26 2022-06-24 0000866291 srt:DirectorMember 2021-03-27 2021-06-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 10-Q
_________________
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 24, 2022
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number: 001-39675
_________________
ALLEGRO MICROSYSTEMS, INC.
(Exact name of registrant as specified in its charter)
_________________

Delaware | 46-2405937
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
955 Perimeter Road |
Manchester, | New Hampshire | 03103
(Address of principal executive offices) | (Zip Code)

(603) 626-2300
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
_________________
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, par value $0.01 per share |  | ALGM |  | The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☒ | Accelerated filer | ☐
Non-accelerated filer |  | ☐ | Smaller reporting company | ☐
|  |  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of July 22, 2022, the registrant had 191,269,633 shares of common stock, $0.01 par value per share, outstanding.

1

TABLE OF CONTENTS

|  | Page
| Forward-Looking Statements | 2
PART I. | Financial Information | 4
Item 1. | Condensed Consolidated Financial Statements | 4
| Condensed Consolidated Balance Sheets as of June 24, 2022 and March 25, 2022 (Unaudited) | 4
| Condensed Consolidated Statements of Operations for the three-month periods ended June 24, 2022 and June 25, 2021 (Unaudited) | 5
| Condensed Consolidated Statements of Comprehensive Income for the three-month periods ended June 24, 2022 and June 25, 2021 (Unaudited) | 6
| Condensed Consolidated Statements of Changes in Equity for the three-month periods ended June 24, 2022 and June 25, 2021 (Unaudited) | 7
| Condensed Consolidated Statements of Cash Flows for the three-month periods ended June 24, 2022 and June 25, 2021 (Unaudited) | 8
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 24
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 40
Item 4. | Controls and Procedures | 41
PART II. | Other Information | 41
Item 1. | Legal Proceedings | 42
Item 1A. | Risk Factors | 42
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42
Item 3. | Defaults Upon Senior Securities | 42
Item 4. | Mine Safety Disclosures | 42
Item 5. | Other Information | 42
Item 6. | Exhibits | 43
Signatures | 44

FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future results of operations and financial position, business strategy, the impact of the ongoing and global COVID-19 pandemic on our business, prospective products and the plans and objectives of management for future operations, may be forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
Statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors and trends affecting our business are forward-looking statements. Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance, or achievements, and one should avoid placing undue reliance on such statements.
Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II. Item 1A. “Risk Factors” in this Quarterly Report and Part II, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 25, 2022 (the “2022 Annual Report”). These risks and uncertainties include, but are not limited to:
•downturns or volatility in general economic conditions, including as a result of the COVID-19 pandemic, particularly in the automotive market;
•our ability to compete effectively, expand our market share and increase our net sales and profitability;
•our reliance on a limited number of third-party wafer fabrication facilities and suppliers of other materials;
•our failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand;
•shifts in our product mix or customer mix, which could negatively impact our gross margin;
•the cyclical nature of the analog semiconductor industry;
•any downturn in the automotive market;
•our ability to compensate for decreases in average selling prices of our products and increases in input costs;
•increases in inflation rates or sustained periods of inflation in the markets in which we operate;
•any disruptions at our primary third-party wafer fabrication facilities;
•our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products;
•our ability to fully realize the benefits of past and potential future initiatives designed to improve our competitiveness, growth and profitability;
•our ability to accurately predict our quarterly net sales and operating results;
•our ability to adjust our supply chain volume to account for changing market conditions and customer demand;
•our reliance on a limited number of third-party wafer fabrication facilities and suppliers of other materials;
•our dependence on manufacturing operations in the Philippines;
•our reliance on distributors to generate sales;
•COVID-19 induced lock-downs and suppression on our supply chain and customer demand;
•our ability to develop new product features or new products in a timely and cost-effective manner;
•our ability to manage growth;
•any slowdown in the growth of our end markets;
•the loss of one or more significant customers;
•our ability to meet customers’ quality requirements;
•uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins;
2

•changes in government trade policies, including the imposition of tariffs and export restrictions;
•our exposures to warranty claims, product liability claims and product recalls;
•our dependence on international customers and operations;
•the availability of rebates, tax credits and other financial incentives on end-user demands for certain products;
•risks related to governmental regulation and other legal obligations, including privacy, data protection, information security, consumer protection, environmental and occupational health and safety, anti-corruption and anti-bribery, and trade controls;
•the volatility of currency exchange rates;
•our ability to raise capital to support our growth strategy;
•our indebtedness may limit our flexibility to operate our business;
•our ability to effectively manage our growth and to retain key and highly skilled personnel;
•our ability to protect our proprietary technology and inventions through patents or trade secrets;
•our ability to commercialize our products without infringing third-party intellectual property rights;
•disruptions or breaches of our information technology systems or those of our third-party service providers;
•our principal stockholders have substantial control over us;
•the inapplicability of the “corporate opportunity” doctrine to any director or stockholder who is not employed by us;
•the dilutive impact on the price of our shares upon future issuance by us or future sales by our stockholders;
•our lack of intent to declare or pay dividends for the foreseeable future;
•anti-takeover provisions in our organizational documents and General Corporation Law of the State of Delaware;
•the exclusive forum provision in our Certificate of Incorporation for disputes with stockholders;
•our inability to design, implement or maintain effective internal control over financial reporting;
•changes in tax rates or the adoption of new tax legislation; and
•other events beyond our control.
Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.
You should read this Quarterly Report and the documents that we reference in this Quarterly Report completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report, whether as a result of any new information, future events or otherwise.
Unless the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Allegro” refer to the operations of Allegro MicroSystems, Inc. and its consolidated subsidiaries.
3

PART I – FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value and share amounts)
(Unaudited)

| June 24, 2022 |  | March 25, 2022
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 286,557 |  |  | $ | 282,383 |
Restricted cash | 9,715 |  |  | 7,416 |
Trade accounts receivable, net of provision for expected credit losses of $149 and $105 at June 24, 2022 and March 25, 2022, respectively | 91,552 |  |  | 87,359 |
Trade and other accounts receivable due from related party | 30,109 |  |  | 27,360 |
Accounts receivable – other | 1,430 |  |  | 4,144 |
Inventories | 88,933 |  |  | 86,160 |
Prepaid expenses and other current assets | 18,863 |  |  | 14,995 |
Current portion of related party note receivable | 1,875 |  |  | 1,875 |
Total current assets | 529,034 |  |  | 511,692 |
Property, plant and equipment, net | 214,808 |  |  | 210,028 |
Operating lease right-of-use assets | 15,158 |  |  | 16,049 |
Deferred income tax assets | 25,505 |  |  | 17,967 |
Goodwill | 19,953 |  |  | 20,009 |
Intangible assets, net | 36,142 |  |  | 35,970 |
Related party note receivable, less current portion | 5,156 |  |  | 5,625 |
Equity investment in related party | 26,807 |  |  | 27,671 |
Other assets, net | 53,550 |  |  | 47,609 |
Total assets | $ | 926,113 |  |  | $ | 892,620 |
Liabilities, Non-Controlling Interests and Stockholders' Equity |  |  |
Current liabilities: |  |  |
Trade accounts payable | $ | 34,492 |  |  | $ | 29,836 |
Amounts due to related party | 4,704 |  |  | 5,222 |
Accrued expenses and other current liabilities | 68,952 |  |  | 65,459 |
Current portion of operating lease liabilities | 3,656 |  |  | 3,706 |
Total current liabilities | 111,804 |  |  | 104,223 |
Obligations due under Senior Secured Credit Facilities | 25,000 |  |  | 25,000 |
Operating lease liabilities, less current portion | 11,893 |  |  | 12,748 |
Other long-term liabilities | 14,056 |  |  | 15,286 |
Total liabilities | 162,753 |  |  | 157,257 |
Commitments and contingencies (Note 13) |  |  |
Stockholders' Equity: |  |  |
Preferred Stock, $0.01 par value; 20,000,000 shares authorized, no shares issued or outstanding at June 24, 2022 and March 25, 2022 | — |  |  | — |
Common stock, $0.01 par value; 1,000,000,000 shares authorized, 191,180,179 shares issued and outstanding at June 24, 2022; 1,000,000,000 shares authorized, 190,473,595 issued and outstanding at March 25, 2022 | 1,912 |  |  | 1,905 |
Additional paid-in capital | 652,317 |  |  | 627,792 |
Retained earnings | 133,205 |  |  | 122,958 |
Accumulated other comprehensive loss | (25,198) |  |  | (18,448) |
Equity attributable to Allegro MicroSystems, Inc. | 762,236 |  |  | 734,207 |
Non-controlling interests | 1,124 |  |  | 1,156 |
Total stockholders' equity | 763,360 |  |  | 735,363 |
Total liabilities, non-controlling interest and stockholders' equity | $ | 926,113 |  |  | $ | 892,620 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
4

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Net sales | $ | 176,044 |  |  | $ | 152,689 |  |  |  |  |
Net sales to related party | 41,709 |  |  | 35,453 |  |  |  |  |
Total net sales | 217,753 |  |  | 188,142 |  |  |  |  |
Cost of goods sold (Note17) | 99,379 |  |  | 93,982 |  |  |  |  |
Gross profit | 118,374 |  |  | 94,160 |  |  |  |  |
Operating expenses: |  |  |  |  |  |  |
Research and development | 33,857 |  |  | 29,554 |  |  |  |  |
Selling, general and administrative | 69,980 |  |  | 32,064 |  |  |  |  |
Change in fair value of contingent consideration | (200) |  |  | 300 |  |  |  |  |
Total operating expenses | 103,637 |  |  | 61,918 |  |  |  |  |
Operating income | 14,737 |  |  | 32,242 |  |  |  |  |
Other income (expense): |  |  |  |  |  |  |
Interest expense, net | (120) |  |  | (345) |  |  |  |  |
Foreign currency transaction gain (loss) | 1,924 |  |  | (254) |  |  |  |  |
(Loss) income in earnings of equity investment | (864) |  |  | 279 |  |  |  |  |
Other, net | (3,429) |  |  | 48 |  |  |  |  |
Income before income taxes | 12,248 |  |  | 31,970 |  |  |  |  |
Income tax provision | 1,965 |  |  | 4,263 |  |  |  |  |
Net income | 10,283 |  |  | 27,707 |  |  |  |  |
Net income attributable to non-controlling interests | 36 |  |  | 38 |  |  |  |  |
Net income attributable to Allegro MicroSystems, Inc. | $ | 10,247 |  |  | $ | 27,669 |  |  |  |  |
Net income attributable to Allegro MicroSystems, Inc. per share: |  |  |  |  |  |  |
Basic | $ | 0.05 |  |  | $ | 0.15 |  |  |  |  |
Diluted | $ | 0.05 |  |  | $ | 0.14 |  |  |  |  |
Weighted average shares outstanding: |  |  |  |  |  |  |
Basic | 190,638,135 |  |  | 189,585,381 |  |  |  |  |
Diluted | 192,406,276 |  |  | 191,163,074 |  |  |  |  |

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(Unaudited)

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Net income | $ | 10,283 |  |  | $ | 27,707 |  |  |  |  |
Net income attributable to non-controlling interest | 36 |  |  | 38 |  |  |  |  |
Net income attributable to Allegro MicroSystems, Inc. | 10,247 |  |  | 27,669 |  |  |  |  |
Other comprehensive loss: |  |  |  |  |  |  |
Foreign currency translation adjustment | (6,818) |  |  | (30) |  |  |  |  |
Comprehensive income | 3,429 |  |  | 27,639 |  |  |  |  |
Other comprehensive loss attributable to non-controlling interest | 68 |  |  | 30 |  |  |  |  |
Comprehensive income attributable to Allegro MicroSystems, Inc. | $ | 3,497 |  |  | $ | 27,669 |  |  |  |  |

The accompanying notes are an integral part of these condensed consolidated financial statements.
6

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(in thousands, except share amounts)
(Unaudited)

|  |  |  |  |  | Preferred Stock |  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Non-Controlling Interests |  | Total Equity
|  |  |  |  |  |  |  |  |  | Shares |  | Amount |  | Shares |  | Amount |  |  |  |  |
Balance at March 26, 2021 |  |  |  |  |  |  |  |  |  | — |  |  | $ | — |  |  | 189,588,161 |  |  | $ | 1,896 |  |  | $ | 592,170 |  |  | $ | 3,551 |  |  | $ | (11,865) |  |  | $ | 1,119 |  |  | $ | 586,871 |
Net income |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 27,669 |  |  | — |  |  | 38 |  |  | 27,707 |
Stock-based compensation, net of forfeitures |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | (6,540) |  |  | — |  |  | 4,831 |  |  | — |  |  | — |  |  | — |  |  | 4,831 |
Foreign currency translation adjustment |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (30) |  |  | (30) |
Balance at June 25, 2021 |  |  |  |  |  |  |  |  |  | — |  |  | $ | — |  |  | 189,581,621 |  |  | $ | 1,896 |  |  | $ | 597,001 |  |  | $ | 31,220 |  |  | $ | (11,865) |  |  | $ | 1,127 |  |  | $ | 619,379 |

|  |  |  |  |  | Preferred Stock |  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Non-Controlling Interests |  | Total Equity
|  |  |  |  |  |  |  |  |  | Shares |  | Amount |  | Shares |  | Amount |  |  |  |  |
Balance at March 25, 2022 |  |  |  |  |  |  |  |  |  | — |  |  | $ | — |  |  | 190,473,595 |  |  | $ | 1,905 |  |  | $ | 627,792 |  |  | $ | 122,958 |  |  | $ | (18,448) |  |  | $ | 1,156 |  |  | $ | 735,363 |
Net income |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10,247 |  |  | — |  |  | 36 |  |  | 10,283 |
Stock-based compensation, net of forfeitures |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | 706,584 |  |  | 7 |  |  | 34,131 |  |  | — |  |  | — |  |  | — |  |  | 34,138 |
Payments of taxes withheld on net settlement of equity awards |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (9,606) |  |  | — |  |  | — |  |  | — |  |  | (9,606) |
Foreign currency translation adjustment |  |  |  |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6,750) |  |  | (68) |  |  | (6,818) |
Balance at June 24, 2022 |  |  |  |  |  |  |  |  |  | — |  |  | $ | — |  |  | 191,180,179 |  |  | $ | 1,912 |  |  | $ | 652,317 |  |  | $ | 133,205 |  |  | $ | (25,198) |  |  | $ | 1,124 |  |  | $ | 763,360 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
7

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)

| Three-Month Period Ended
| June 24, 2022 |  | June 25, 2021
CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
Net income | $ | 10,283 |  |  | $ | 27,707 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 11,918 |  |  | 12,172 |
Amortization of deferred financing costs | 24 |  |  | 25 |
Deferred income taxes | (7,784) |  |  | (1,454) |
Stock-based compensation | 34,136 |  |  | 4,831 |
Gain on disposal of assets | (3) |  |  | (35) |
(Gain) loss on contingent consideration change in fair value | (200) |  |  | 300 |
Provisions for inventory and expected credit losses | 2,640 |  |  | 1,613 |
Unrealized loss on marketable securities | 3,486 |  |  | — |
Changes in operating assets and liabilities: |  |  |
Trade accounts receivable | (4,718) |  |  | (9,956) |
Accounts receivable - other | 2,714 |  |  | (97) |
Inventories | (4,888) |  |  | 5,142 |
Prepaid expenses and other assets | (13,102) |  |  | 1,719 |
Trade accounts payable | 4,075 |  |  | (2,993) |
Due to/from related parties | (3,267) |  |  | 1,917 |
Accrued expenses and other current and long-term liabilities | 1,239 |  |  | (2,396) |
Net cash provided by operating activities | 36,553 |  |  | 38,495 |
CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
Purchases of property, plant and equipment | (14,389) |  |  | (15,346) |
Net cash used in investing activities | (14,389) |  |  | (15,346) |
CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
Receipts on related party note receivable | 469 |  |  | — |
Payments for taxes related to net share settlement of equity awards | (9,606) |  |  | — |
Net cash used in financing activities | (9,137) |  |  | — |
Effect of exchange rate changes on Cash and cash equivalents and Restricted cash | (6,554) |  |  | 2,608 |
Net increase in Cash and cash equivalents and Restricted cash | 6,473 |  |  | 25,757 |
Cash and cash equivalents and Restricted cash at beginning of period | 289,799 |  |  | 203,875 |
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD: | $ | 296,272 |  |  | $ | 229,632 |
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH: |  |  |
Cash and cash equivalents at beginning of period | $ | 282,383 |  |  | $ | 197,214 |
Restricted cash at beginning of period | 7,416 |  |  | 6,661 |
Cash and cash equivalents and Restricted cash at beginning of period | $ | 289,799 |  |  | $ | 203,875 |
Cash and cash equivalents at end of period | 286,557 |  |  | 221,934 |
Restricted cash at end of period | 9,715 |  |  | 7,698 |
Cash and cash equivalents and Restricted cash at end of period | $ | 296,272 |  |  | $ | 229,632 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |  |  |
Cash paid for interest | $ | 452 |  |  | $ | 269 |
Cash refunded for income taxes | (1,027) |  |  | (538) |
Noncash transactions: |  |  |
Trade accounts payable related to Property, plant and equipment, net | $ | (2,602) |  |  | $ | (5,535) |
Noncash lease liabilities arising from obtaining right-of-use assets | 150 |  |  | 356 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
8

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except share and per share amounts)
1. Nature of the Business and Basis of Presentation
Allegro MicroSystems, Inc., together with its consolidated subsidiaries (“AMI” or the “Company”), is a global leader in designing, developing and manufacturing sensing and power solutions for motion control and energy-efficient systems in automotive and industrial markets. The Company is headquartered in Manchester, New Hampshire and has a global footprint across multiple continents.
The accompanying unaudited condensed consolidated financial statements have been prepared by the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements include the Company's accounts and those of its subsidiaries. All intercompany balances have been eliminated in consolidation. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on May 18, 2022 (the “2022 Annual Report”). In the opinion of the Company’s management, the financial information for the interim periods presented reflects all adjustments necessary for a fair statement of the Company’s financial position, results of operations and cash. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of results that may be expected for the entire year.
Financial Periods
The Company’s first quarter three-month period is a 13-week period ending on the Friday closest to the last day in June. The Company’s first quarter of fiscal 2023 ended June 24, 2022, and the Company’s first quarter of fiscal 2022 ended June 25, 2021.
2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures of contingencies at the date of the unaudited condensed consolidated financial statements and the reported amounts of net sales and expenses during the reporting period. Such estimates relate to useful lives of fixed and intangible assets, allowances for expected credit losses and customer returns and sales allowances. Such estimates could also relate to the fair value of acquired assets and liabilities, including goodwill and intangible assets, net realizable value of inventory, accrued liabilities, the valuation of stock-based awards, deferred tax valuation allowances, and other reserves. On an ongoing basis, management evaluates its estimates. Actual results could differ from those estimates, and such differences may be material to the unaudited condensed consolidated financial statements.
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents with financial institutions, which management believes to be of a high credit quality. To manage credit risk related to accounts receivables, the Company evaluates the creditworthiness of its customers and maintains allowances, to the extent necessary, for potential credit losses based upon the aging of its accounts receivable balances and known collection issues. The Company has not experienced any significant credit losses during the prior two years.
As of June 24, 2022 and March 25, 2022, Sanken Electric Co., Ltd. (“Sanken”) accounted for 24.7% and 23.8% of the Company’s outstanding trade accounts receivable, net, respectively, including related party trade accounts receivable. No other customers accounted for 10% or more of outstanding trade accounts receivable, net during those periods.
For the three months ended June 24, 2022 and June 25, 2021, Sanken accounted for 19.2% and 18.8% of total net sales, respectively. No other customers accounted for 10% or more of total net sales for either of the three months ended June 24, 2022 or June 25, 2021.
9

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
During the three months ended June 24, 2022, sales from customers located outside of the United States accounted for, in the aggregate, 87.0% of the Company’s total net sales, with Greater China accounting for 25.3% and Japan accounting for 19.2%. No other countries accounted for greater than 10% of total net sales for the three months ended June 24, 2022.
During the three months ended June 25, 2021, sales from customers located outside of the United States, in the aggregate, accounted for 85.7% of the Company’s total net sales, with Greater China accounting for 22.7%, Japan accounting for 18.8% and South Korea accounting for 11.7%. No other countries accounted for greater than 10% of total net sales for the three months ended June 25, 2021.
Recently Adopted Accounting Standards
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), which eliminates the diversity in practice and inconsistency related to the accounting for acquired revenue contracts with customers in a business combination. The amendments in ASU 2021-08 require an acquiring entity to apply ASC Topic 606, Contracts with Customers (“ASC 606”), to recognize and measure contract assets and contract liabilities in a business combination as if the acquired contracts with customers were originated by the acquiring entity at the acquisition date. An acquirer may assess how the acquiree applied ASC 606 and generally should recognize and measure the acquired contract assets and contract liabilities consistent with the recognition and measurement in the acquiree’s financial statements, as prepared in accordance with U.S. GAAP. If unable to rely on the acquiree’s accounting due to errors, noncompliance with U.S. GAAP, or differences in accounting policies, the acquirer should consider the terms of the acquired contracts, such as timing of payment, identify each performance obligation in the contracts, and allocate the total transaction price to each identified performance obligation on a relative standalone selling price basis as of contract inception (that is, the date the acquiree entered into the contracts) or contract modification to determine what should be recorded at the acquisition date. The Company early adopted ASU 2021-08, effective March 26, 2022 and concluded that adoption of this ASU did not have a material impact on its financial position, results of operations, cash flows, or related disclosures. The Company will apply the guidance in ASU 2021-08 prospectively to all business combinations that occur after the date of adoption.
In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2021-04”). ASU 2021-04 outlines how an entity should account for modifications made to equity-classified written call options, including stock options and warrants to purchase the entity’s own common stock. The guidance in the ASU requires an entity to treat a modification of an equity-classified written call option that does not cause the option to become liability-classified as an exchange of the original option for a new option. This guidance applies whether the modification is structured as an amendment to the terms and conditions of the equity-classified written call option or as termination of the original option and issuance of a new option. The Company adopted ASU 2021-04, effective March 26, 2022, and concluded that it did not have a material impact on its financial position, results of operations, cash flows, or related disclosures.
Recently Issued Accounting Standards Not Yet Adopted
None applicable.
3. Revenue from Contracts with Customers
The Company generates revenue from the sale of magnetic sensor integrated circuits (“ICs”) and application-specific analog power semiconductors. The following tables summarize net sales disaggregated by application, by product and by geography for the three months ended June 24, 2022 and June 25, 2021. The categorization of net sales by application is determined using various characteristics of the product and the application into which the Company’s product will be incorporated. The categorization of net sales by geography is determined based on the location to which the products are shipped.
10

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
Net sales by application:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Automotive | $ | 149,649 |  |  | $ | 133,523 |  |  |  |  |
Industrial | 40,140 |  |  | 30,309 |  |  |  |  |
Other | 27,964 |  |  | 24,310 |  |  |  |  |
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  |  |  |

Net sales by product:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Power integrated circuits | $ | 80,660 |  |  | $ | 66,672 |  |  |  |  |
Magnetic sensors | 137,050 |  |  | 120,642 |  |  |  |  |
Photonics | 43 |  |  | 828 |  |  |  |  |
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  |  |  |

Net sales by geography:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Americas: |  |  |  |  |  |  |
United States | $ | 28,391 |  |  | $ | 26,841 |  |  |  |  |
Other Americas | 6,487 |  |  | 6,349 |  |  |  |  |
EMEA: |  |  |  |  |  |  |
Europe | 35,333 |  |  | 34,751 |  |  |  |  |
Asia: |  |  |  |  |  |  |
Japan | 41,709 |  |  | 35,453 |  |  |  |  |
Greater China | 55,116 |  |  | 42,779 |  |  |  |  |
South Korea | 20,979 |  |  | 21,933 |  |  |  |  |
Other Asia | 29,738 |  |  | 20,036 |  |  |  |  |
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  |  |  |

The Company recognizes sales net of returns, credits issued, price protection adjustments and stock rotation rights. At June 24, 2022 and March 25, 2022, these adjustments were $14,399 and $14,924, respectively, and were netted against trade accounts receivable in the unaudited condensed consolidated balance sheets. These amounts represent activity of income of $525 and $1,613 for the three months ended June 24, 2022 and June 25, 2021, respectively.
Unsatisfied performance obligations primarily represent contracts for products with future delivery dates. The Company elected not to disclose the amount of unsatisfied performance obligations as these contracts have original expected durations of less than one year.
11

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
4. Fair Value Measurements
The following tables present information about the Company’s financial assets and liabilities as of June 24, 2022 and March 25, 2022 measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:

| Fair Value Measurement at June 24, 2022 Using:
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Money market fund deposits | $ | 96,395 |  |  | $ | — |  |  | $ | — |  |  | $ | 96,395 |
Restricted cash: |  |  |  |  |  |  |
Money market fund deposits | 9,715 |  |  | — |  |  | — |  |  | 9,715 |
Other assets, net (long-term): |  |  |  |  |  |  |
Investments in marketable securities | 8,538 |  |  | — |  |  | — |  |  | 8,538 |
Total assets | $ | 114,648 |  |  | $ | — |  |  | $ | — |  |  | $ | 114,648 |
Liabilities: |  |  |  |  |  |  |
Other long-term liabilities: |  |  |  |  |  |  |
Contingent consideration | $ | — |  |  | $ | — |  |  | $ | 2,600 |  |  | $ | 2,600 |
Total liabilities | $ | — |  |  | $ | — |  |  | $ | 2,600 |  |  | $ | 2,600 |

| Fair Value Measurement at March 25, 2022 Using:
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Money market fund deposits | $ | 16,927 |  |  | $ | — |  |  | $ | — |  |  | $ | 16,927 |
Restricted cash: |  |  |  |  |  |  |
Money market fund deposits | 7,416 |  |  | — |  |  | — |  |  | 7,416 |
Other assets, net (long-term): |  |  |  |  |  |  |
Investments in marketable securities | 12,346 |  |  | — |  |  | — |  |  | 12,346 |
Total assets | $ | 36,689 |  |  | $ | — |  |  | $ | — |  |  | $ | 36,689 |
Liabilities: |  |  |  |  |  |  |
Other long-term liabilities: |  |  |  |  |  |  |
Contingent consideration | — |  |  | — |  |  | 2,800 |  |  | 2,800 |
Total liabilities | $ | — |  |  | $ | — |  |  | $ | 2,800 |  |  | $ | 2,800 |

The following table represents the unrealized gains and losses on investments in marketable securities held with a readily determinable fair value for the three months ended June 24, 2022:

Net losses recognized during the period on equity securities | $ | (3,486) |  |  |
Less: Net gains and losses recognized during the period on equity securities sold during the period | — |  |  |
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date | $ | (3,486) |  |  |

In addition to the unrealized gains in the table above, the change in fair value of the equity securities was impacted by unrealized foreign currency exchange losses of $323 for the three months ended June 24, 2022. There were no investments in marketable securities during the three months ended June 25, 2021.
In connection with the fiscal year 2021 purchase of Voxtel, Inc. (“Voxtel”), a privately held technology company located in Beaverton, Oregon, that develops, manufactures and supplies photonic and advanced 3D imaging technologies (the “Voxtel Acquisition”), the Company is required to make contingent payments, subject to the entity achieving certain sales and revenue thresholds. The contingent consideration payments are up to $15,000. The fair value of the liabilities for the contingent payments recognized upon the Voxtel Acquisition as part of the purchase accounting opening balance sheet
12

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
totaled $7,300 and was estimated by discounting to present value the probability-weighted contingent payments expected to be made. Assumptions used in this calculation were units sold, expected revenue, discount rate and various probability factors. The ultimate settlement of contingent consideration could deviate from current estimates based on the actual results of these financial measures. This liability is considered to be a Level 3 financial liability that is remeasured during each reporting period. The change in fair value of contingent consideration for the Voxtel Acquisition is included in change in fair value of contingent consideration in the unaudited condensed consolidated statements of operations.
The following table shows the change in fair value of Level 3 contingent consideration in connection with an acquisition in fiscal year 2021 for the three-month periods ended June 24, 2022 and June 25, 2021:

| Level 3 Contingent Consideration
Balance at March 25, 2022 | $ | 2,800 |
Change in fair value of contingent consideration | (200) |
Balance at June 24, 2022 | $ | 2,600 |
Balance at March 26, 2021 | $ | 4,800 |
Change in fair value of contingent consideration | 300 |
Balance at June 25, 2021 | $ | 5,100 |

Assets and liabilities measured at fair value on a recurring basis also consist of marketable securities, unit investment trust funds, loans, bonds, stock and other investments which are the Company’s defined benefit plan assets. Fair value information for those assets and liabilities, including their classification in the fair value hierarchy, is included in Note 12, “Retirement Plans.”
During the three months ended June 24, 2022 and June 25, 2021, there were no transfers among Level 1, Level 2 and Level 3 asset or liabilities.
5. Trade Accounts Receivable, net
Trade accounts receivable, net (including related party trade accounts receivable) consisted of the following:

| June 24, 2022 |  | March 25, 2022
Trade accounts receivable | $ | 136,032 |  |  | $ | 129,539 |
Less: |  |  |
Provision for expected credit losses | (149) |  |  | (105) |
Returns and sales allowances | (14,250) |  |  | (14,819) |
Related party trade accounts receivable | (30,081) |  |  | (27,256) |
Total | $ | 91,552 |  |  | $ | 87,359 |

13

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
The Company is exposed to credit losses primarily through trade and other financing receivables arising from revenue transactions. The Company uses an aging schedule method to estimate current expected credit losses (“CECL”) based on days of delinquency, including information about past events and current economic conditions. The Company’s accounts receivable are separated into two categories using a portfolio methodology to evaluate the allowance under the CECL impairment model based on sales categorization and similar credit quality and worthiness of the customers: original equipment manufacturers (“OEMs”) and distributors. The receivables in each category share similar risk characteristics. The Company increases the provision for expected credits losses when the Company determines all or a portion of a receivable is uncollectible, and the Company recognizes recoveries as a decrease to the provision for expected credit losses.
Changes in the Company’s expected credit losses and returns and sales allowances were as follows:

Description |  | Provision for Expected Credit Losses |  | Returns and Sales Allowances |  | Total
Balance at March 25, 2022 |  | $ | 105 |  |  | $ | 14,819 |  |  | $ | 14,924 |
Charged to costs and expenses or revenue |  | 44 |  |  | 27,753 |  |  | 27,797 |
Settlements, net of recoveries |  | — |  |  | (28,322) |  |  | (28,322) |
Balance at June 24, 2022 |  | $ | 149 |  |  | $ | 14,250 |  |  | $ | 14,399 |
Balance at March 26, 2021 |  | $ | 138 |  |  | $ | 15,274 |  |  | $ | 15,412 |
Charged to costs and expenses or revenue |  | 635 |  |  | 40,582 |  |  | 41,217 |
Settlements, net of recoveries |  | — |  |  | (42,830) |  |  | (42,830) |
Balance at June 25, 2021 |  | $ | 773 |  |  | $ | 13,026 |  |  | $ | 13,799 |

6. Inventories
Inventories include material, labor and overhead and consisted of the following:

| June 24, 2022 |  | March 25, 2022
Raw materials and supplies | $ | 12,334 |  |  | $ | 11,941 |
Work in process | 57,661 |  |  | 55,855 |
Finished goods | 18,938 |  |  | 18,364 |
Total | $ | 88,933 |  |  | $ | 86,160 |

The Company recorded inventory write-offs totaling $2,115 and $3,189 for the three months ended June 24, 2022 and June 25, 2021, respectively.
7. Property, Plant and Equipment, net
Property, plant and equipment, net is stated at cost, and consisted of the following:

| June 24, 2022 |  | March 25, 2022
Land | $ | 15,374 |  |  | $ | 15,775 |
Buildings, building improvements and leasehold improvements | 58,518 |  |  | 59,816 |
Machinery and equipment | 558,373 |  |  | 542,745 |
Office equipment | 6,128 |  |  | 6,247 |
Construction in progress | 22,229 |  |  | 22,428 |
Total | 660,622 |  |  | 647,011 |
Less accumulated depreciation | (445,814) |  |  | (436,983) |
Total | $ | 214,808 |  |  | $ | 210,028 |

Total depreciation expense amounted to $10,850 and $11,120 for the three months ended June 24, 2022 and June 25, 2021, respectively.
14

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
Long-lived assets include property, plant and equipment and related deposits on such assets, and capitalized tooling costs. The geographic locations of the Company's long-lived assets, net, based on physical location of the assets, as of June 24, 2022 and March 25, 2022 are as follows:

| June 24, 2022 |  | March 25, 2022
United States | $ | 35,606 |  |  | $ | 35,221 |
Philippines | 171,318 |  |  | 167,488 |
Other | 8,491 |  |  | 7,746 |
Total | $ | 215,415 |  |  | $ | 210,455 |

Amortization of prepaid tooling costs amounted to $32 and $33 for the three months ended June 24, 2022 and June 25, 2021, respectively.
8. Goodwill and Intangible Assets
The table below summarizes the changes in the carrying amount of goodwill as follows:

| Total
Balance at March 25, 2022 | $ | 20,009 |
Foreign currency translation | (56) |
Balance at June 24, 2022 | $ | 19,953 |
Balance at March 26, 2021 | $ | 20,106 |
Foreign currency translation | 12 |
Balance at June 25, 2021 | $ | 20,118 |

Intangible assets, net is as follows:

|  | June 24, 2022
Description |  | Gross |  | Accumulated Amortization |  | Net Carrying Amount |  | Weighted-Average Lives
Patents |  | $ | 37,604 |  |  | $ | 15,860 |  |  | $ | 21,744 |  |  | 10 years
Customer relationships |  | 6,806 |  |  | 6,590 |  |  | 216 |  |  | 9 years
Process technology |  | 13,100 |  |  | 2,015 |  |  | 11,085 |  |  | 12 years
Indefinite-lived and legacy process technology |  | 4,050 |  |  | 1,650 |  |  | 2,400 |  |  |
Trademarks |  | 200 |  |  | 74 |  |  | 126 |  |  | 5 years
Legacy trademarks |  | 629 |  |  | 58 |  |  | 571 |  |  |
Other |  | 32 |  |  | 32 |  |  | — |  |  |
Total |  | $ | 62,421 |  |  | $ | 26,279 |  |  | $ | 36,142 |  |  |

|  | March 25, 2022
Description |  | Gross |  | Accumulated Amortization |  | Net Carrying Amount |  | Weighted-Average Lives
Patents |  | $ | 36,577 |  |  | $ | 15,304 |  |  | $ | 21,273 |  |  | 10 years
Customer relationships |  | 6,582 |  |  | 6,348 |  |  | 234 |  |  | 9 years
Process technology |  | 13,100 |  |  | 1,742 |  |  | 11,358 |  |  | 12 years
Indefinite-lived and legacy process technology |  | 4,050 |  |  | 1,650 |  |  | 2,400 |  |  |
Trademarks |  | 200 |  |  | 64 |  |  | 136 |  |  | 5 years
Legacy trademarks |  | 627 |  |  | 58 |  |  | 569 |  |  |
Other |  | 32 |  |  | 32 |  |  | — |  |  |
Total |  | $ | 61,168 |  |  | $ | 25,198 |  |  | $ | 35,970 |  |  |

Intangible assets amortization expense was $1,036 and $1,019 for the three months ended June 24, 2022 and June 25, 2021, respectively. The majority of the Company’s intangible assets are related to patents, as noted above.
15

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
As of June 24, 2022, annual amortization expense of intangible assets for the next five fiscal years is expected to be as follows:

Remainder of 2023 | $ | 2,942 |
2024 | 3,758 |
2025 | 3,499 |
2026 | 3,240 |
2027 | 2,926 |
Thereafter | 16,806 |
Total | $ | 33,171 |

9. Accrued Expenses and Other Current Liabilities
The composition of accrued expenses and other current liabilities is as follows:

| June 24, 2022 |  | March 25, 2022
Accrued management incentives | $ | 9,814 |  |  | $ | 33,607 |
Accrued salaries and wages | 23,313 |  |  | 14,699 |
Accrued vacation | 7,140 |  |  | 5,715 |
Accrued severance | 4,308 |  |  | 839 |
Accrued professional fees | 5,219 |  |  | 1,252 |
Accrued income taxes | 11,161 |  |  | 1,831 |
Accrued utilities | 2,157 |  |  | 607 |
Other current liabilities | 5,840 |  |  | 6,909 |
Total | $ | 68,952 |  |  | $ | 65,459 |

10. Debt and Other Borrowings
On September 30, 2020, the Company entered into a term loan credit agreement with Credit Suisse AG, Cayman Islands Branch, as administrative agent and collateral agent, and the other agents, arrangers and lenders party thereto, providing for a $325,000 senior secured term loan facility due in 2028 (the “Term Loan Facility”). On September 30, 2020, the Company also entered into a revolving facility credit agreement with Mizuho Bank, Ltd., as administrative agent and collateral agent, and the other agents, arrangers and lenders party thereto, providing for a $50,000 senior secured revolving credit facility expiring in 2023 (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facilities”). The Company’s outstanding borrowings bore an interest rate of 4.81% at June 24, 2022. As of both June 24, 2022 and March 25, 2022, the Company had $25,000 outstanding under the Term Loan Facility and had not borrowed on the Revolving Credit Facility. As of June 24, 2022 and March 25, 2022, the unamortized portion of the deferred financing costs associated with the Revolving Credit Facility was $124 and $149, respectively, and the related short-term and long-term portions were classified within “Prepaid expenses and other current assets” and “Other assets” on its unaudited condensed consolidated balance sheets.
On November 26, 2019, the Company, through its subsidiaries, entered into a line of credit agreement with a financial institution that provides for a maximum borrowing capacity of 60,000 Philippine pesos (approximately $1,102 at June 24, 2022) at the bank’s prevailing interest rate. The line of credit is due to expire on August 31, 2022. There were no borrowings outstanding under this line of credit as of June 24, 2022 and March 25, 2022.
On November 20, 2019, the Company, through its subsidiaries, entered into a line of credit agreement with a financial institution that provides for a maximum capacity of 75,000 Philippine pesos (approximately $1,378 at June 24, 2022) at the bank’s prevailing interest rate. The line of credit is due to expire on June 30, 2023. There were no borrowings outstanding under this line of credit as of June 24, 2022 and March 25, 2022.
16

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
11. Other Long-Term Liabilities
The composition of other long-term liabilities is as follows:

| June 24, 2022 |  | March 25, 2022
Accrued management incentives | $ | 31 |  |  | $ | 826 |
Accrued retirement | 8,646 |  |  | 8,903 |
Accrued contingent consideration | 2,600 |  |  | 2,800 |
Provision for uncertain tax positions (net) | 2,779 |  |  | 2,757 |
Total | $ | 14,056 |  |  | $ | 15,286 |

12. Retirement Plans
The Company recognizes the funded status (i.e., the difference between the fair value of plan assets and the benefit obligations) of its defined benefit pension plans in its unaudited condensed consolidated balance sheets with a corresponding adjustment to accumulated other comprehensive income, net of tax. These amounts will continue to be recognized as a component of future net periodic benefit costs consistent with the Company’s past practice. Further, actuarial gains and losses and prior service costs that arise in future periods and are not recognized as net periodic benefit costs in the same periods will be recognized as a component of other comprehensive income. Those amounts will also be recognized as a component of future net periodic benefit costs consistent with the Company’s past practice. The Company uses a measurement date for its defined benefit pension plans and other postretirement benefit plans that is equivalent to its fiscal year-end.
Plan Descriptions
Non-U.S. Defined Benefit Plan
The Company, through its wholly owned subsidiary, Allegro MicroSystems Philippines, Inc. (“AMPI”), has a defined benefit pension plan, which is a noncontributory plan that covers substantially all employees of the respective subsidiary. The plan’s assets are invested in common trust funds, bonds and other debt instruments and stocks.
Effect on the unaudited statements of operations
Expense related to the non-United States (“U.S.”) defined benefit plan was as follows:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Service cost | $ | 328 |  |  | $ | 383 |  |  |  |  |
Interest cost | 197 |  |  | 166 |  |  |  |  |
Expected return on plan assets | (78) |  |  | (79) |  |  |  |  |
Amortization of prior service cost | (2) |  |  | — |  |  |  |  |
Actuarial loss | 21 |  |  | 53 |  |  |  |  |
Net periodic pension expense | $ | 466 |  |  | $ | 523 |  |  |  |  |

17

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
Information on Plan Assets
The table below sets forth the fair value of the entity’s plan assets as of June 24, 2022 and March 25, 2022, using the same three-level hierarchy of fair value inputs described in the significant accounting policies included in the Company’s 2022 Annual Report.

| Fair Value at June 24, 2022 |  | Level 1 |  | Level 2 |  | Level 3
Assets of non-U.S. defined benefit plan: |  |  |  |  |  |  |
Government securities | $ | 1,834 |  |  | $ | 1,834 |  |  | $ | — |  |  | $ | — |
Unit investment trust fund | 1,194 |  |  | — |  |  | 1,194 |  |  | — |
Loans | 555 |  |  | — |  |  | — |  |  | 555 |
Bonds | 607 |  |  | — |  |  | 607 |  |  | — |
Stocks and other investments | 2,193 |  |  | 1,166 |  |  | 2 |  |  | 1,025 |
Total | $ | 6,383 |  |  | $ | 3,000 |  |  | $ | 1,803 |  |  | $ | 1,580 |

| Fair Value at March 25, 2022 |  | Level 1 |  | Level 2 |  | Level 3
Assets of non-U.S. defined benefit plan: |  |  |  |  |  |  |
Government securities | $ | 1,920 |  |  | $ | 1,920 |  |  | $ | — |  |  | $ | — |
Unit investment trust fund | 1,165 |  |  | — |  |  | 1,165 |  |  | — |
Loans | 553 |  |  | — |  |  | — |  |  | 553 |
Bonds | 676 |  |  | — |  |  | 676 |  |  | — |
Stocks and other investments | 2,783 |  |  | 1,716 |  |  | 2 |  |  | 1,065 |
Total | $ | 7,097 |  |  | $ | 3,636 |  |  | $ | 1,843 |  |  | $ | 1,618 |

The following table shows the change in fair value of Level 3 plan assets for the three months ended June 24, 2022 and June 25, 2021:

| Level 3 Non-U.S. Defined Plan Assets
| Loans |  | Stocks
Balance at March 25, 2022 | $ | 553 |  |  | $ | 1,065 |
Additions during the year | 171 |  |  | — |
Redemptions during the year | (152) |  |  | — |
Revaluation of equity securities | 4 |  |  | — |
Change in foreign currency exchange rates | (21) |  |  | (40) |
Balance at June 24, 2022 | $ | 555 |  |  | $ | 1,025 |
Balance at March 26, 2021 | $ | 584 |  |  | $ | 1,133 |
Additions during the year | 159 |  |  | — |
Redemptions during the year | (107) |  |  | — |
Revaluation of equity securities | (1) |  |  | — |
Change in foreign currency exchange rates | (2) |  |  | (3) |
Balance at June 25, 2021 | $ | 633 |  |  | $ | 1,130 |

The investments in the Company’s major benefit plans largely consist of low-cost, broad-market index funds to mitigate risks of concentration within the market sectors. In recent years, the Company’s investment policy has shifted toward a closer matching of the interest-rate sensitivity of the plan assets and liabilities. The appropriate mix of equity and bond investments is determined primarily through the use of detailed asset-liability modeling studies that look to balance the impact of changes in the discount rate against the need to provide asset growth to cover future service cost. The Company,
18

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
through its wholly owned subsidiary, Allegro MicroSystems, LLC’s (“AML”), non-U.S. defined benefit plan, has added a greater proportion of fixed income securities with return characteristics that are more closely aligned with changes in liabilities caused by discount rate volatility. There are no significant restrictions on the amount or nature of the investments that may be acquired or held by the plans.
During the three months ended June 24, 2022 and June 25, 2021, the Company contributed approximately $372 and $353 to its non-U.S. pension plan, respectively. The Company expects to contribute approximately $1,546 to its non-U.S. pension plan in fiscal year 2023.
Other Defined Benefit Plans
In December 1993, the Company commenced with a rollover pension promise agreement (“Pension Promise”) to offer a then European employee an insured annuity upon their retirement at age 65. The employee was the only eligible participant of the Pension Promise. The impact associated with the expense and related other income with the Pension Promise was insignificant in fiscal years 2022 and 2021, respectively. The total values of the Pension Promise in the amounts of 684 and 661 British Pounds Sterling at June 24, 2022 and March 25, 2022, respectively (approximately $838 and $875 at June 24, 2022 and March 25, 2022, respectively), were classified with other in other assets, net and accrued retirement in other long-term liabilities in the Company’s unaudited condensed consolidated balance sheets.
Defined Contribution Plan
The Company has a 401(k) plan that covers all employees meeting certain service and age requirements. Employees are eligible to participate in the plan upon hire when the service and age requirements are met. Employees may contribute up to 35% of their compensation, subject to the maximum contribution allowed by the Internal Revenue Service. All employees are 100% vested in their contributions at the time of plan entry.
Eligible AML U.S. employees may contribute up to 50% of their pretax compensation to a defined contribution plan, subject to certain limitations, and AML may match, at its discretion, 100% of the participants’ pretax contributions, up to a maximum of 5% of their eligible compensation. Matching contributions by AML totaled approximatel y $1,430 and $1,256 for the three months ended June 24, 2022 and June 25, 2021, respectively.
The Company, through its AML subsidiary, Allegro MicroSystems Europe, Ltd. (“Allegro Europe”), also has a defined contribution plan (the “AME Plan”) covering substantially all employees of Allegro Europe. Contributions to the AME Plan by the Company totaled approximately $256 and $218 for the three months ended June 24, 2022 and June 25, 2021, respectively.
13. Commitments and Contingencies
Insurance
The Company, through its subsidiaries, utilizes self-insured employee health programs for employees in the United States. The Company records estimated liabilities for its self-insured health programs based on information provided by the third-party plan administrators, historical claims experience and expected costs of claims incurred but not reported. The Company monitors its estimated liabilities on a quarterly basis. As facts change, it may become necessary to make adjustments that could be material to the Company’s unaudited condensed consolidated financial position and results of operations.
Legal proceedings
The Company is subject to various legal proceedings and claims, the outcomes of which are subject to significant uncertainty. The Company records an accrual for legal contingencies when it is determined that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In making such determinations, the Company evaluates, among other things, the degree of probability of an unfavorable outcome and, when it is probable that a liability has been incurred, the ability to make a reasonable estimate of the loss. If the occurrence of liability is probable, the Company will disclose the nature of the contingency, and if estimable, will provide the likely amount of such loss or range of loss. Furthermore, the Company does not believe there are any matters that could have a material adverse effect on financial position, results of operations or cash flows.
19

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
Indemnification
From time to time, the Company has agreed to indemnify and hold harmless certain customers for potential allegations of infringement of intellectual property rights and patents arising from the use of its products. To date, the Company has not recognized or incurred any costs in connection with such indemnification arrangements; therefore, there was no accrual of such amounts at June 24, 2022 or March 25, 2022.
Environmental Matters
The Company establishes accrued liabilities for environmental matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If the contingency is resolved for an amount greater or less than the accrual, or the Company’s share of the contingency increases or decreases or other assumptions relevant to the development of the estimate were to change, the Company would recognize an additional expense or benefit in the unaudited condensed consolidated statements of operations during the period such determination was made. No significant environmental accruals were established at June 24, 2022 or March 25, 2022.
14. Net Income per Share
The following table sets forth the basic and diluted net income attributable to Allegro MicroSystems, Inc. per share.

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Net income attributable to Allegro MicroSystems, Inc. | $ | 10,247 |  |  | $ | 27,669 |  |  |  |  |
Net income attributable to common stockholders | 10,283 |  |  | 27,707 |  |  |  |  |
Basic weighted average shares of common stock | 190,638,135 |  |  | 189,585,381 |  |  |  |  |
Dilutive effect of common stock equivalents | 1,768,141 |  |  | 1,577,693 |  |  |  |  |
Diluted weighted average shares of common stock | 192,406,276 |  |  | 191,163,074 |  |  |  |  |
Basic net income attributable to Allegro MicroSystems, Inc. per share | $ | 0.05 |  |  | $ | 0.15 |  |  |  |  |
Basic net income attributable to common stockholders per share | $ | 0.05 |  |  | $ | 0.15 |  |  |  |  |
Diluted net income attributable to Allegro MicroSystems, Inc. per share | $ | 0.05 |  |  | $ | 0.14 |  |  |  |  |
Diluted net income attributable to common stockholders per share | $ | 0.05 |  |  | $ | 0.14 |  |  |  |  |

The computed net income per share for the three months ended June 24, 2022 and June 25, 2021 does not assume conversion of securities that would have an antidilutive effect on income per share. For the three months ended June 24, 2022 and June 25, 2021, there were 19,272 and 1,988 restricted share units (“RSUs”), respectively, excluded as conversion of such securities would have an antidilutive effect on income per share. For the three months ended June 24, 2022 and June 25, 2021, there were 46,991 and no performance share units (“PSUs”), respectively, excluded as conversion of such securities would have an antidilutive effect on income per share.
The following table represents issuable weighted average share information for the respective periods:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Restricted stock units | 668,259 |  |  | 820,221 |  |  |  |  |
Performance stock units | 1,080,201 |  |  | 752,235 |  |  |  |  |
Employee stock purchase plan | 19,681 |  |  | 5,237 |  |  |  |  |
Total | 1,768,141 |  |  | 1,577,693 |  |  |  |  |

15. Common Stock and Stock-Based Compensation
The Company accounts for stock-based compensation through the measurement and recognition of compensation expense for share-based payment awards made to employees over the related requisite service period, including PSUs, RSUs and restricted shares (all part of our equity incentive plan).
20

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
During the three months ended June 24, 2022 and June 25, 2021, the Company granted RSUs to employees of 1,959,952 and 894,876, respectively, with an estimated grant date fair value of $22.89 and $24.79, respectively. During the three months ended June 24, 2022 and June 25, 2021, 1,031,565 and 3,217 shares vested, respectively, and 120,270 and 28,152 shares were cancelled, respectively. Stock-based compensation expense related to non-vested awards not yet recorded at June 24, 2022 was $47,863, which is expected to be recognized over a weighted-average of 1.73 years.
PSUs are included at 87% - 200% of target goals. The intrinsic value of the PSU’s vested during the three months ended June 24, 2022 and June 25, 2021 was $27,002 and $30,490, respectively. A total of 855,916 and no shares vested during the three months ended June 24, 2022 and June 25, 2021, respectively. The total compensation cost related to non-vested awards not yet recorded at June 24, 2022 was $14,024, which is expected to be recognized over a weighted average of 1.52 years.
During the three months ended June 24, 2022 and June 25, 2021, 18,953 and 54,729 shares of the Company’s restricted common stock, respectively, vested. In addition, No shares and 9,757 shares, respectively, were forfeited, which reduced common stock outstanding during the same periods. The Company had 121,573 unvested shares of restricted common stock at June 24, 2022 with a weighted average grant date fair value of $14.00 and remaining vesting period of 0.82 years.
The Company recorded stock-based compensation expense in the following expense categories of its unaudited condensed consolidated statements of operations:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Cost of sales | $ | 832 |  |  | $ | 528 |  |  |  |  |
Research and development | 1,128 |  |  | 752 |  |  |  |  |
Selling, general and administrative | 32,176 |  |  | 3,551 |  |  |  |  |
Total stock-based compensation | $ | 34,136 |  |  | $ | 4,831 |  |  |  |  |

During the first fiscal quarter of 2023, the Company’s (former) President and Chief Executive Officer, Ravi Vig, provided notice of his retirement from the Company and its board of directors (the “Board”), effective June 13, 2022. Additionally, the Company entered into a second amended and restated severance agreement (the “Second A&R Severance Agreement”) with Mr. Vig that amended and restated the amended agreement from September 30, 2020. As provided for in the Second A&R Severance Agreement, the Company agreed, in addition to other cash-settled and health insurance-related compensation, to modifications to Mr. Vig’s stock-based compensation, including: (i) acceleration of the vesting of all unvested RSUs, (ii) modification of certain PSUs with performance conditions that had been achieved as of the retirement date to permit these awards to remain outstanding and eligible to vest in accordance with their terms, and (iii) the forfeiture of certain unvested PSUs with performance conditions that had not been achieved as of the retirement date and replacement thereof with new immediately vesting RSUs. The impact of these modifications on stock-based compensation expense was $26,349 for the three months ended June 24, 2022, which was recorded in selling, general and administrative expense in the Company’s unaudited condensed consolidated statements of operations.
16. Income Taxes
The Company recorded the following tax provision in its unaudited condensed consolidated statements of operations:

| Three-Month Period Ended |  |
| June 24, 2022 |  | June 25, 2021 |  |  |  |
Provision for income taxes | $ | 1,965 |  |  | $ | 4,263 |  |  |  |  |
Annual operating tax rate | 16.3 | % |  | 15.9 % |  |  |  |
Effective tax rate | 16.0 | % |  | 13.3 | % |  |  |  |

The Company’s provision for income taxes is comprised of the year-to-date taxes based on an estimate of the annual effective tax rate plus the tax impact of discrete items.
The Company is subject to tax in the U.S. and various foreign jurisdictions. The Company’s effective tax rate can fluctuate primarily based on: the mix of its U.S. and foreign income; the impact of discrete transactions; and the difference
21

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
between the amount of tax benefit generated by the foreign derived intangible income deduction (“FDII”) and research credits offset by the additional tax from the global intangible low-tax income.
The quarter ending June 25, 2021 effective tax rate was favorably impacted by one-time state tax refunds. Current year IRC Section 174 capitalization (“174 Capitalization”) resulted in increased U.S. taxable income and cash taxes: however, it also produced an additional FDII benefit of $9,000 with offsetting inclusions from Subpart F of $2,837. The net current year benefits of 174 Capitalization were offset by an increase in current year non-deductible executive compensation of approximately $6,721.
The Company regularly assesses the likelihood of outcomes that could result from the examination of its tax returns by the IRS and other tax authorities to determine the adequacy of its income tax reserves and expense. Should actual events or results differ from the Company’s then-current expectations, charges or credits to the Company’s provision for income taxes may become necessary. Any such adjustments could have a significant effect on the results of operations.
17. Related Party Transactions
Transactions involving Sanken
The Company sells products to, and purchases in-process products from, Sanken. As of June 24, 2022, Sanken held approximately 51.5% of the Company’s outstanding common stock.
Net sales of Company products to Sanken totaled $41,709 and $35,453 during the three months ended June 24, 2022 and June 25, 2021, respectively. Although certain costs are commingled, shared or allocated, cost of goods sold and gross margins attributable to related party sales are consistent with those of third-party customers. Trade accounts receivables, net of allowances from Sanken, totaled $30,081 and $27,256 as of June 24, 2022 and March 25, 2022, respectively. Other accounts receivable from Sanken totaled $28 and $104 as of June 24, 2022 and March 25, 2022, respectively.
Termination of Sanken Distribution Agreement
In May 2022, the Company entered into a letter of intent with Sanken to develop a plan to transition the supply chain and sales activity in Japan from Sanken to the Company. During the planning process, both parties will define the transition timeline and method for customer communication, supply chain transfer and sales coverage. The Company and Sanken will also define a method to continue engagement with Sanken on the support of select customers.
Transactions involving Polar Semiconductor, LLC (“PSL”)
The Company purchases in-process products from PSL. PSL is a subsidiary of Sanken, 70% owned by Sanken and 30% owned by the Company.
Purchases of various products from PSL totaled $14,671 and $13,380 for the three months ended June 24, 2022 and June 25, 2021, respectively. Accounts payable to PSL included in amounts due to related party totaled $4,704 and $5,222 as of June 24, 2022 and March 25, 2022, respectively.
On December 2, 2021, AML entered into a loa n agreement with PSL wherein PSL provided an initial promissory note to AML for a principal amount of $7,500 (the “Initial PSL Loan”). The Initial PSL Loan will be repaid in equal installments, comprising principal and interest accrued at 1.26% per annum, over a term of four years with payments due on the first day of each calendar year quarter (April 1, July 1, October 1, and January 1). In addition, PSL has the option of borrowing up to an additional $7,500 under the same terms of the PSL Loan (the “Secondary PSL Loan” and, together with the Initial PSL Loan, the “PSL Promissory Notes”). The loan funds will be used by PSL to procure a deep ultraviolet scan ner and other associated manufacturing tools necessary to increase wafer fabrication capacity in support of the Company’s increasing wafer demand. As of June 24, 2022, the outstanding balance of the PSL Promissory Notes was $7,031. During the three months ended June 24, 2022, PSL made a quarterly payment to AML of $500, which included $31 of interest income. On July 1, 2022, PSL made a quarterly payment to AML of $491, which included $22 of interest income.
During the first quarter of 2023, PSL informed the Company of its election to draw upon the Secondary PSL Loan. The Secondary PSL Loan was funded to PSL on July 1, 2022.
Sublease Agreement
In 2014, the Company, through one of its subsidiaries, entered into a sublease agreement with Sanken pursuant to which it subleases certain office building space in Japan from Sanken. The sublease automatically renews on an annual basis unless either party provides notice to the other party otherwise and can be terminated by either party upon providing six
22

ALLEGRO MICROSYSTEMS, INC.
Notes to Unaudited Condensed Consolidated Financial Statements – (continued)
(Amounts in thousands, except share and per share amounts)
months’ notice. The Company made aggregate payments of approximately $48 and $56 to Sanken under the sublease agreement during the three months ended June 24, 2022 and June 25, 2021, respectively.
Consulting Agreement
In September 2017 and prior to Reza Kazerounian becoming a member of the Board, the Company entered into a board executive advisor agreement, as amended in June 2018 (the “Consulting Agreement”), with Mr. Kazerounian, pursuant to which the Company engaged Mr. Kazerounian to serve as executive advisor to the Board and the office of Chief Executive Officer. The Consulting Agreement provides for a fee payable to Mr. Kazerounian on a monthly basis in exchange for his services. The Consulting Agreement provides that if Mr. Kazerounian is terminated by the Board, he will be entitled to a severance payment in the amount of $180. The Board and Mr. Kazerounian each have the right to terminate the Consulting Agreement at any time. During the three months ended June 24, 2022 and June 25, 2021, the Company paid aggregate fees of $72 and $56, respectively, to Mr. Kazerounian pursuant to the Consulting Agreement.
Employment Relationship
On June 20, 2022, the Board elected Kojiro Hatano to the Board as a class II director, to serve until the Company’s 2022 annual meeting of shareholders and until his successor is duly elected and qualified. Mr. Hatano was elected to the Board as a designee of Sanken pursuant to the Company’s Amended and Restated Stockholders Agreement, dated as of June 16, 2022. Mr. Hatano has served as Manager of Business Performance for the Company since January 2006. During the three months ended June 24, 2022 and June 25, 2021, Mr. Hatano received compensation, consisting of salary, benefits and reimbursement of living expenses of approximately $51 and $48, respectively, from the Company. This amount was partially reimbursed to the Company by Sanken.
23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes and other information included elsewhere in this Quarterly Report, as well as the audited financial statements and the related notes thereto, and the discussion under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” included in our Annual Report on Form 10-K for the year ended March 25, 2022, filed with the Securities and Exchange Commission (“SEC”) on May 18, 2022 (the “2022 Annual Report”).
In addition to historical data, this discussion contains forward-looking statements about our business, results of operations, cash flows, financial condition and prospects based on current expectations that involve risks, uncertainties and assumptions. Our actual results could differ materially from such forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the section titled “Forward-Looking Statements” and in Part I, Item 1A. “Risk Factors” of our 2022 Annual Report and Part II. Item 1A. “Risk Factors” of this Quarterly Report. Additionally, our historical results are not necessarily indicative of the results that may be expected for any period in the future.
We operate on a 52- or 53-week fiscal year ending on the last Friday of March. Each fiscal quarter has 13 weeks, except in a 53-week year, when the fourth fiscal quarter has 14 weeks such as in fiscal year 2023. All references to the three months ended June 24, 2022 and June 25, 2021 relate to the 13-week periods ended June 24, 2022 and June 25, 2021, respectively. All references to “2022,” “fiscal year 2022” or similar references relate to the 52-week period ended March 25, 2022.
Overview
Allegro MicroSystems, Inc., together with its consolidated subsidiaries (“AMI”, “we”, “us” or “our”) is a leading global designer, developer, manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling the most important emerging technologies in the automotive and industrial markets. We are a leading supplier of magnetic sensor IC solutions worldwide based on market share, driven by our market leadership in automotive. We focus on providing complete IC solutions to sense, regulate and drive a variety of mechanical systems. This includes sensing the angular or linear position of a shaft or actuator, driving an electric motor or actuator, and regulating the power applied to sensing and driving circuits so they operate safely and efficiently.
We are headquartered in Manchester, New Hampshire and have a global footprint with 17 locations across four contine nts. Our portfolio includes more than 1,000 products, and we ship over one billion units annually to more than 10,000 customers worldwide. Du ring the three months ended June 24, 2022 and June 25, 2021, we generated $217.8 million and $188.1 million in total net sales, respectively, with $10.3 million and $27.7 million in net income, respectively, and $66.7 million an d $53.8 million in Adjusted EBITDA in such fiscal periods, respectively. For additional information regarding Adjusted EBITDA, a non-GAAP financial measure, please refer to “Non-GAAP Financial Measures” in this document.
Recent Initiatives to Improve Results of Operations
We implemented several initiatives during the fiscal year 2022 and into fiscal year 2023 designed to improve our operating results during those fiscal years and going forward.
We continue to implement initiatives to improve gross margins, which is calculated as gross profit divided by total net sales. Our gross margin improved from 50.0% in the first quarter of 2022 compared to 54.4% in the first quarter of 2023. This gross margin improvement was a result of our operational transformation, improved product mix of higher average selling prices (“ASPs”) on more value-added products, increased leverage of our distribution channel, and continued efficiency and leverage on higher volumes. We expect to continue to realize this lower level of cost of goods and improvements in operating income for the immediate future. Additionally, we will continue to leverage our facility to increase production where demand for our products warrants.
We have been successful in increasing our ASPs through a focus on feature-rich products and selective price increases. Increased ASPs and manufacturing efficiencies have allowed us to continue to improve gross margin in an environment of limited capacity at our suppliers and rising input costs. Limited supply and increased demand for many of our products and applications, as well as supply chain disruptions related to the COVID-19 pandemic, have contributed to input cost increases on the components needed to manufacture our products. We will continue to consider opportunities for strategic price increases and process efficiencies to offset input cost increases on the materials and supplies that we use in production.
24

With our efforts to leverage our fixed cost and operating margin improvements, we have attained efficiencies through cost structure improvements, streamlining of manufacturing and support processes, and further utilization of excess capacity. These manufacturing efficiencies allowed us to leverage higher volumes to keep pace with increasing demand across most of our applications, while reducing cost of goods sold and increasing the absorption of fixed costs. Although these initiatives have resulted in gross margin and operating income improvements over the previous quarters, we cannot ensure that these trends will continue over the long-term.
In May 2022, we entered into an agreement to acquire Heyday Integrated Circuits (“Heyday”), a privately held company specializing in compact, fully integrated isolated gate drivers that enable energy conversion in high-voltage gallium nitride and silicon carbide wide-bandgap semiconductor designs (the “Heyday Acquisition”). The Heyday Acquisition is expected to complement our existing solutions for energy efficiency, including our market-leading current sensor solutions. Additionally, it is expected to significantly expand Allegro’s addressable market for xEV, solar inverters, data center and 5G power supplies, and broad-market industrial applications. We are currently awaiting regulatory approval of the transaction, and we anticipate completion of the acquisition by the third quarter of fiscal 2023.
Other Key Factors and Trends Affecting our Operating Results
Our financial condition and results of operations have been, and will continue to be, affected by numerous other factors and trends, including the following:
Inflation
Inflation rates in the markets in which we operate have increased and may continue to rise. Inflation over the last several months has led us to experience higher costs, including higher labor costs, wafer and other costs for materials from suppliers, and transportation costs. Our suppliers have raised their prices and may continue to raise prices, and in the competitive markets in which we operate, we may not be able to make corresponding price increases to preserve our gross margins and profitability. If inflation rates continue to rise or remain elevated for a sustained period of time, they could have a material adverse effect on our business, financial condition, results of operations and l iquidity.We have generally been able to offset increases in these costs through various productivity and cost reduction initiatives, as well as adjusting our selling prices to pass through some of these higher costs to our customers; however, our ability to raise our selling prices depends on market conditions and competitive dynamics. Given the timing of our actions compared to the timing of these inflationary pressures, there may be periods during which we are unable to fully recover the increases in our costs.
Design Wins with New and Existing Customers
Our end customers continually develop new products in existing and new application areas, and we work closely with our significant OEM customers in most of our target markets to understand their product roadmaps and strategies. For new products, the time from design initiation and manufacturing until we generate sales can be lengthy, typically between two and four years. As a result, our future sales is highly dependent on our continued success at winning design mandates from our customers. Further, despite current inflationary and pricing conditions, we expect the ASPs of our products to decline over time, and we consider design wins to be critical to our future success and anticipate being increasingly dependent on revenue from newer design wins for our newer products. The selection process is typically lengthy and may require us to incur significant design and development expenditures in pursuit of a design win with no assurance that our solutions will be selected. As a result, the loss of any key design win or any significant delay in the ramp-up of volume production of the customer’s products into which our product is designed could adversely affect our business. In addition, volume production is contingent upon the successful introduction and market acceptance of our customers’ end products, which may be affected by several factors beyond our control.
Customer Demand, Orders and Forecasts
Demand for our products is highly dependent on market conditions in the end markets in which our customers operate, which are generally subject to seasonality, cyclicality and competitive conditions. In addition, a substantial portion of our total net sales is derived from sales to customers that purchase large volumes of our products. These customers generally provide periodic forecasts of their requirements, but these forecasts do not commit such customers to minimum purchases, and customers can revise these forecasts without penalty. In addition, as is customary in the semiconductor industry, customers are generally permitted to cancel orders for our products within a specified period. While historically we have permitted order cancellations for most customers, most of our current customer order backlog is noncancellable, which helps to mitigate our exposure to unforeseen order cancellations. However, cancellations of orders could still result in the loss of anticipated sales without allowing us sufficient time to reduce our inventory and operating expenses. In addition, changes in forecasts or the timing of orders from customers exposes us to the risks of inventory shortages or excess inventory. We continue to see demand for our products exceed supply, and we are currently operating in an inflationary environment.
25

Manufacturing Costs and Product Mix
Gross margin has been, and will continue to be, affected by a variety of factors, including the ASPs of our products, product mix in a given period, material costs, yields, manufacturing costs and efficiencies. We believe the primary driver of gross margin is the ASP negotiated between us and our customers relative to material costs and yields. Our pricing and margins depend on the volumes and the features of the products we produce and sell to our customers. As our products mature and unit volumes increase, despite current price leverage, we expect their ASPs to decline in the long term. We continually monitor and work to reduce the cost of our products and improve the potential value our solutions provide to our customers as we target new design win opportunities and manage the product life-cycles of our existing customer designs. We also maintain a close relationship with our suppliers and subcontractors to improve quality, increase yields and lower manufacturing costs. As a result, these declines often coincide with improvements in manufacturing yields and lower wafer, assembly, and testing costs, which offset some or all of the margin reduction that results from declining ASPs. However, we expect our gross margin to fluctuate on a quarterly basis as a result of changes in ASPs due to product mix, new product introductions, transitions into volume manufacturing and manufacturing costs. Gross margin generally decreases if production volumes are lower as a result of decreased demand, which leads to a reduced absorption of our fixed manufacturing costs. Gross margin generally increases when the opposite occurs.
Cyclical Nature of the Semiconductor Industry
The semiconductor industry has historically been highly cyclical and is characterized by increasingly rapid technological change, product obsolescence, competitive pricing pressures, evolving standards, short product life-cycles and fluctuations in product supply and demand. New technology may result in sudden changes in system designs or platform changes that may render some of our products obsolete and require us to devote significant research and development resources to compete effectively. Periods of rapid growth and capacity expansion are occasionally followed by significant market corrections in which sales decline, inventories accumulate and facilities go underutilized. During periods of expansion, our margins generally improve as fixed costs are spread over higher manufacturing volumes and unit sales. In addition, we may build inventory to meet increasing market demand for our products during these times, which serves to absorb fixed costs further and increase our gross margins. During an expansion cycle, we may increase capital spending and hiring to add to our production capacity. During periods of slower growth or industry contractions, our sales, production and productivity suffer and margins generally decline.
Components of Our Results of Operations
Net sales
Our total net sales are derived from product sales to direct customers and distributors. We sell products globally through our direct sales force, third-party and related party distributors and independent sales representatives. Sales are derived from products for different applications. Our core applications are focused on the automotive, industrial and other industries.
We sell magnetic sensor ICs, power ICs and photonics in the Americas, EMEA and Asia. Revenue is generally recognized when control of the products is transferred to the customer, which typically occurs at a point in time upon shipment or delivery, depending on the terms of the contract. When we transact with a distributor, our contractual arrangement is with the distributor and not with the end customer. Whether we transact business with and receive the order from a distributor or directly from an end customer through our direct sales force and independent sales representatives, our revenue recognition policy and resulting pattern of revenue recognition for the order are the same. We recognize revenue net of sales returns, price protection adjustments, stock rotation rights and any other discounts or credits offered to our customers.
Cost of goods sold, gross profit and gross margin
Cost of goods sold consists primarily of costs of purchasing raw materials, costs associated with probe, assembly, testing and shipping our products, costs of personnel, including stock-based compensation, costs of equipment associated with manufacturing, procurement, planning and management of these processes, costs of depreciation and amortization, costs of logistics and quality assurance, and costs of royalties, value-added taxes, utilities, repairs and maintenance of equipment, and an allocated portion of our occupancy costs.
Gross profit is calculated as total net sales less cost of goods sold. Gross profit is affected by numerous factors, including average selling price, revenue mix by product, channel and customer, foreign exchange rates, seasonality, manufacturing costs and the effective utilization of our facilities. Another factor impacting gross profit is the time required
26

for the expansion of existing facilities to reach full production capacity. As a result, gross profit varies from period to period and year to year.
A significant portion of our costs is fixed, and, as a result, costs are generally difficult to adjust or may take time to adjust in response to changes in demand. In addition, our fixed costs increase as we expand our capacity. If we expand capacity faster than required by our sales growth, our gross margin could be negatively affected. Gross margin is calculated as gross profit divided by total net sales.
Operating Expenses
Research and development (“R&D”) expenses
R&D expenses consist primarily of personnel-related costs of our research and development organization, including stock-based compensation, costs of development of wafers and masks, license fees for computer-aided design software, costs of development testing and evaluation, costs of developing automated test programs, equipment depreciation and related occupancy and equipment costs. While most of the costs incurred are for new product development, a significant portion of these costs is related to process technology development and proprietary package development. R&D expenses also include costs for technology development by external parties. We expect further increases in R&D expenses, in absolute dollars, as we continue the development of innovative technologies and processes for new product offerings, as well as increase the headcount of our R&D personnel in future years.
Selling, General and Administrative (“SG&A”) expenses
SG&A expenses consist primarily of personnel-related costs, including stock-based compensation, and sales commissions to independent sales representatives, professional fees, including the costs of accounting, audit, legal, regulatory and tax compliance. Additionally, costs related to advertising, trade shows, corporate marketing, as well as an allocated portion of our occupancy costs, also comprise SG&A expenses.
We anticipate our selling and marketing expenses to increase in absolute terms as we expand our sales force and increase our sales and marketing activities.
Change in fair value of contingent consideration
The change in fair value of contingent consideration represents the gain recorded in the three months ended June 24, 2022 resulting from the adjustment in contingent consideration related to the acquisition of Voxtel, Inc. (“Voxtel”).
Interest expense, net
Interest expense, net is comprised of interest expense from term loan debt and credit facilities we maintain with various financial institutions. Current expense is partially mitigated by income earned on our cash and cash equivalents, consisting primarily of certain investments that have contractual maturities no greater than three months at the time of purchase.
Foreign currency transaction gain (loss)
We incur transaction gains and losses resulting from intercompany transactions as well as transactions with customers or vendors denominated in currencies other than the functional currency of the legal entity in which the transaction is recorded.
(Loss) income in earnings of equity investment
(Loss) income in earnings of equity investment is related to our equity investment in PSL.
Other, net
Other, net primarily consists of miscellaneous income and expense items unrelated to our core operations.
Income tax provision
Our provision for income taxes is based on an estimate of the annual effective tax rate plus the tax impact of discrete items.
We are subject to tax in the U.S. and various foreign jurisdictions. Our effective income tax rate fluctuates primarily because of: the change in the mix of our U.S. and foreign income; the impact of discrete transactions and law changes; and the difference between the amount of tax benefits generated by the foreign derived intangible income deduction (“FDII”) and
27

research credits, offset by the additional tax costs associated with global intangible low-tax income and non-deductible stock-based compensation charges.
Pursuant to impacts of the 2017 Tax Cuts and Jobs Act, beginning in fiscal year 2023, U.S. tax law now requires us to capitalize and amortize domestic and foreign research and development expenditures over five and fifteen years, respectively (“174 Capitalization”). While it is possible that Congress may defer, modify, or repeal this provision, potentially with retroactive effect, we have no assurance that this provision will be reversed. Although our first quarter fiscal 2023 cash from operations was not materially impacted, if legislation is not passed and made effective retroactively, we estimate the impact of this legislative change will increase our annual cash taxes by $21.0 million and produce an increased FDII effective tax rate benefit. The actual impact of 174 Capitalization on cash taxes and the effective tax rate depends on if Congress passes additional legislation, whether such legislation is made effective retroactively, the amount of the research and development expenditures incurred by the Company during the fiscal year, and upon additional guidance the Internal Revenue Service (“IRS”) may issue related to this provision.
We regularly assess the likelihood of outcomes that could result from the examination of our tax returns by the IRS and other tax authorities to determine the adequacy of our income tax reserves and expense. Should actual events or results differ from our then-current expectations, charges or credits to our provision for income taxes may become necessary. Any such adjustments could have a significant effect on our results of operations.
Results of Operations
Three-Month Period Ended June 24, 2022 Compared to Three-Month Period Ended June 25, 2021
The following table summarizes our results of operations for the three-month periods ended June 24, 2022 and June 25, 2021.

| Three-Month Period Ended |  | Change
| June 24, 2022 |  | June 25, 2021 |  | $ |  | %
| (Dollars in thousands)
Total net sales (1) | $ | 217,753 |  |  | $ | 188,142 |  |  | $ | 29,611 |  |  | 15.7 | %
Cost of goods sold | 99,379 |  |  | 93,982 |  |  | 5,397 |  |  | 5.7 | %
Gross profit | 118,374 |  |  | 94,160 |  |  | 24,214 |  |  | 25.7 | %
Operating expenses: |  |  |  |  |  |  |
Research and development | 33,857 |  |  | 29,554 |  |  | 4,303 |  |  | 14.6 | %
Selling, general and administrative | 69,980 |  |  | 32,064 |  |  | 37,916 |  |  | 118.3 | %
Change in fair value of contingent consideration | (200) |  |  | 300 |  |  | (500) |  |  | (166.7) | %
Total operating expenses | 103,637 |  |  | 61,918 |  |  | 41,719 |  |  | 67.4 | %
Operating income | 14,737 |  |  | 32,242 |  |  | (17,505) |  |  | (54.3) | %
Other income (expense), net: |  |  |  |  |  |  |
Interest expense, net | (120) |  |  | (345) |  |  | 225 |  |  | (65.2) | %
Foreign currency transaction gain (loss) | 1,924 |  |  | (254) |  |  | 2,178 |  |  | (857.5) | %
(Loss) income in earnings of equity investment | (864) |  |  | 279 |  |  | (1,143) |  |  | (409.7) | %
Other, net | (3,429) |  |  | 48 |  |  | (3,477) |  |  | (7,243.8) | %
Total other expense, net | (2,489) |  |  | (272) |  |  | (2,217) |  |  | 815.1 | %
Income before income tax provision | 12,248 |  |  | 31,970 |  |  | (19,722) |  |  | (61.7) | %
Income tax provision | 1,965 |  |  | 4,263 |  |  | (2,298) |  |  | (53.9) | %
Net income | 10,283 |  |  | 27,707 |  |  | (17,424) |  |  | (62.9) | %
Net income attributable to non-controlling interests | 36 |  |  | 38 |  |  | (2) |  |  | (5.3) | %
Net income attributable to Allegro MicroSystems, Inc. | $ | 10,247 |  |  | $ | 27,669 |  |  | $ | (17,422) |  |  | (63.0) | %

(1)Our total net sales for the periods presented above include related party net sales generated through our distribution agreement with Sanken. See our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report for additional information regarding our related party net sales for the periods set forth above.
28

The following table sets forth our results of operations as a percentage of total net sales for the periods presented.

| Three-Month Period Ended
| June 24, 2022 |  | June 25, 2021
Total net sales | 100.0 | % |  | 100.0 | %
Cost of goods sold | 45.6 | % |  | 50.0 | %
Gross profit | 54.4 | % |  | 50.0 | %
Operating expenses: |  |  |
Research and development | 15.5 | % |  | 15.7 | %
Selling, general and administrative | 32.1 | % |  | 17.0 | %
Change in fair value of contingent consideration | (0.1) | % |  | 0.2 | %
Total operating expenses | 47.5 | % |  | 32.9 | %
Operating income | 6.9 | % |  | 17.1 | %
Other income (expense), net: |  |  |
Interest expense, net | (0.1) | % |  | (0.2) | %
Foreign currency transaction gain (loss) | 0.9 | % |  | (0.2) | %
(Loss) income in earnings of equity investment | (0.4) | % |  | 0.1 | %
Other, net | (1.6) | % |  | 0.1 | %
Total other expense, net | (1.2) | % |  | (0.2) | %
Income before income tax provision | 5.7 | % |  | 16.9 | %
Income tax provision | 1.0 | % |  | 2.3 | %
Net income | 4.7 | % |  | 14.6 | %
Net income attributable to non-controlling interests | — | % |  | — | %
Net income attributable to Allegro MicroSystems, Inc. | 4.7 | % |  | 14.6 | %

Total net sales
Total net sales increased by $29.6 million, or 15.7%, to $217.8 million in the three-month period ended June 24, 2022 from $188.1 million in the three-month period ended June 25, 2021. This increase was primarily attributable to higher shipment of our data center, advanced driver assistance systems (“ADAS”), electrified vehicle (“xEV”), and computing applications.
Sales Trends by Market
The following table summarizes total net sales by market. The categorization of net sales by market is based on the characteristics of the end product and application into which our product will be designed.

| Three-Month Period Ended |  | Change
| June 24, 2022 |  | June 25, 2021 |  | Amount |  | %
| (Dollars in thousands)
Automotive | $ | 149,649 |  |  | $ | 133,523 |  |  | $ | 16,126 |  |  | 12.1 | %
Industrial | 40,140 |  |  | 30,309 |  |  | 9,831 |  |  | 32.4 | %
Other | 27,964 |  |  | 24,310 |  |  | 3,654 |  |  | 15.0 | %
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  | $ | 29,611 |  |  | 15.7 | %

The increase in net sales to our end markets was driven primarily by increases in automotive o f $16.1 million, or 12.1%, industrial of $9.8 million, or 32.4%, and other of $3.7 million, or 15.0%.
Automotive net sales increased in the three-month period ended June 24, 2022 compared to the three-month period ended June 25, 2021, primarily due to higher demand for our ADAS and xEV applications.
Industrial net sales increased in the three-month period ended June 24, 2022 compared to the three-month period ended June 25, 2021, primarily due to increased demand in data center and Industry 4.0 applications.
29

Other net sales improved during the three-month period ended June 24, 2022 compared to the three-month period ended June 25, 2021, mainly due to increases in demand for certain computer products.
Sales Trends by Product
The following table summarizes net sales by product:

| Three-Month Period Ended |  | Change
| June 24, 2022 |  | June 25, 2021 |  | Amount |  | %
| (Dollars in thousands)
Power integrated circuits (“PIC”) | $ | 80,660 |  |  | $ | 66,672 |  |  | $ | 13,988 |  |  | 21.0 | %
Magnetic sensors (“MS”) | 137,050 |  |  | 120,642 |  |  | 16,408 |  |  | 13.6 | %
Photonics | 43 |  |  | 828 |  |  | (785) |  |  | (94.8) | %
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  | $ | 29,611 |  |  | 15.7 | %

The increase in net sales by product was driven by increases of $16.4 million, or 13.6%, in MS product sales and $14.0 million, or 21.0%, in PIC product sales, partially offset by a decrease of $0.8 million in Photonics sales.
Sales Trends by Geographic Location
The following table summarizes net sales by geographic location based on ship-to location.

| Three-Month Period Ended |  | Change
| June 24, 2022 |  | June 25, 2021 |  | Amount |  | %
| (Dollars in thousands)
Americas: |  |  |  |  |  |  |
United States | $ | 28,391 |  |  | $ | 26,841 |  |  | $ | 1,550 |  |  | 5.8 | %
Other Americas | 6,487 |  |  | 6,349 |  |  | 138 |  |  | 2.2 | %
EMEA: |  |  |  |  |  |  |
Europe | 35,333 |  |  | 34,751 |  |  | 582 |  |  | 1.7 | %
Asia: |  |  |  |  |  |  |
Japan | 41,709 |  |  | 35,453 |  |  | 6,256 |  |  | 17.6 | %
Greater China | 55,116 |  |  | 42,779 |  |  | 12,337 |  |  | 28.8 | %
South Korea | 20,979 |  |  | 21,933 |  |  | (954) |  |  | (4.3) | %
Other Asia | 29,738 |  |  | 20,036 |  |  | 9,702 |  |  | 48.4 | %
Total net sales | $ | 217,753 |  |  | $ | 188,142 |  |  | $ | 29,611 |  |  | 15.7 | %

Net sales increased across the majority of our geographic locations in the three-month period ended June 24, 2022 compared to the three-month period ended June 25, 2021, primarily due to content and market share gains, as demand for many of our products and applications continue to rise.
The increase in net sales of $12.3 million, or 28.8%, in Greater China related to higher automotive demand, primarily in our ADAS and xEV offerings. Other Asia experienced sales growth of $9.7 million, or 48.4%, mainly in our data center sector. Net sales in Japan grew $6.3 million, or 17.6%, which was primarily driven by higher demand for our safety, comfort and convenience, xEV and industrial applications. The increase in net sales in the United States of $1.6 million, or 5.8%, was primarily driven by content and market share gains in our ADAS applications.
Cost of goods sold, gross profit and gross margin
Cost of goods sold increased by $5.4 million, or 5.7%, to $99.4 million in the three-month period ended June 24, 2022 from $94.0 million in the three-month period ended June 25, 2021. The increase in cost of goods sold was primarily attributable to higher sales volume.
Gross p rofit increased by $24.2 million, or 25.7%, to $118.4 million in the three-month period ended June 24, 2022 from $94.2 million in the three-month period ended June 25, 2021. The increase in gross profit was driven by the $29.6
30

million increase in total net sales to all end markets discussed above, partially offset by the impacts to cost of goods sold discussed above.
R&D expenses
R&D expenses increased by $4.3 million, or 14.6%, to $33.9 million in the three-month period ended June 24, 2022 from $29.6 million in the three-month period ended June 25, 2021. This increase was primarily due to a combined $3.8 million increase in personnel costs, including variable compensation costs, and general operating expenses and higher stock-based compensation expense of $0.4 million.
R&D expenses represen ted 15.5% of our total net sales for the three-month period ended June 24, 2022, a decrease from 15.7% of our total net sales for the three-month period ended June 25, 2021. This percentage decrease was primarily due to the growth in net sales in the three-month period ended June 24, 2022.
SG&A expenses
SG&A expen ses increased by $38.0 million, or 118.3%, to $70.0 million in the three-month period ended June 24, 2022 from $32.1 million in the three-month period ended June 25, 2021. This increase was primarily due to an increase of $28.6 million in stock-based compensation expense, including accelerated expense from the retirement of our former chief executive officer of approximately $26.3 million, as well as higher personnel costs, including variable compensation costs, of $4.4 million and combined costs of $1.6 million comprised of professional fees and dues and subscription costs. In addition, we recognized $3.8 million of severance and other transition costs mainly due to the combined impacts of our recent changes in leadership.
SG&A expenses represented 32.1% of our total net sales for the three-month period ended June 24, 2022, an increase from 17.0% of our total net sales for the three-month period ended June 25, 2021. This percentage increase was primarily due to the impacts noted above, partially offset by growth in net sales in the three-month period ended June 24, 2022.
Interest expense, net
Interest exp ense, net was $0.1 million in the three-month period ended June 24, 2022 compared to $0.3 million in the three-month period ended June 25, 2021. The decrease in interest expense was primarily due to higher interest income received from a related party in the first quarter of 2023. The mandatory interest payments on the Term Loan Facility remained relatively consistent.
Foreign currency transaction gain (loss)
We recorded a foreign currency transaction gain of $1.9 million in the three-month period ended June 24, 2022 compared to a loss of $0.3 million in the three-month period ended June 25, 2021. The foreign currency transaction gains or losses recorded in each three-month period were primarily due to the realized and unrealized gains or losses from our UK location.
(Loss) income in earnings of equity investment
(Loss) income in earnings of equity investment reflected losses of $0.9 million and gains of $0.3 million in the three-month period ended June 24, 2022 and June 25, 2021, respectively, representing the earnings on our 30% investment in PSL.
Other, net
Other, net decreased by $3.5 million to a loss of more than $3.4 million in the three-month period ended June 24, 2022 from less than $0.1 million of gains in the three-month period ended June 25, 2021. The decrease in the three-month period ended June 24, 2022 was primarily due to $3.5 million of unrealized losses on marketable securities.
Income tax provision
Income tax expense and the effective income tax rate wer e $2.0 million, or 16.0%, and $4.3 million, or 13.3%, respectively, in the three-month period ended June 24, 2022 and June 25, 2021, respectively. The quarter ending June 25, 2021 effective tax rate was favorably impacted by one-time state tax refunds. Current year 174 Capitalization resulted in increased U.S. taxable income and cash taxes; however, it also produced an additional FDII benefit of $9.0 million with offsetting inclusions from Subpart F of $2.8 million. The net current year benefits of 174 Capitalization were offset by an increase in current year non-deductible executive compensation of approximately $6.7 million.
Non-GAAP Financial Measures
In addition to the measures presented in our consolidated financial statements, we regularly review other measures,
31

defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, non-GAAP Profit before Tax, non-GAAP Provision for Income Tax, non-GAAP Net Income, non-GAAP Net Earnings per Share, EBITDA, Adjusted EBITDA and Adjusted EBITDA margin (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Provision for Income Tax, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Provision for Income Taxes across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. By presenting these Non-GAAP Financial Measures, we provide a basis for comparison of our business operations between periods by excluding items that we do not believe are indicative of our core operating performance, and we believe that investors’ understanding of our performance is enhanced by our presenting these Non-GAAP Financial Measures, as they provide a reasonable basis for comparing our ongoing results of operations. Management believes that tracking and presenting these Non-GAAP Financial Measures provides management and the investment community with valuable insight into matters such as: our ongoing core operations; our ability to generate cash to service our debt and fund our operations; and the underlying business trends that are affecting our performance. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities. In particular, management finds it useful to exclude non-cash charges in order to better correlate our operating activities with our ability to generate cash from operations and to exclude certain cash charges as a means of more accurately predicting our liquidity requirements. We believe that these Non-GAAP Financial Measures, when used in conjunction with our GAAP financial information, also allow investors to better evaluate our financial performance in comparison to other periods and to other companies in our industry.
These Non-GAAP Financial Measures have significant limitations as analytical tools. Some of these limitations are that:
•such measures do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;
•such measures exclude certain costs which are important in analyzing our GAAP results;
•such measures do not reflect changes in, or cash requirements for, our working capital needs;
•such measures do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
•such measures do not reflect our tax expense or the cash requirements to pay our taxes;
•although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future;
•certain measures do not reflect any cash requirements for such replacements; and
•other companies in our industry may calculate such measures differently than we do, thereby further limiting their usefulness as comparative measures.
The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items.
Our prior disclosure referred to non-GAAP Gross Profit and non-GAAP Gross Margin as Adjusted Gross Profit and Adjusted Gross Margin, respectively. No changes have been made to how we calculate these measures.
Non-GAAP Gross Profit and Non-GAAP Gross Margin
We calculate non-GAAP Gross Profit and non-GAAP Gross Margin excluding the items below from cost of goods sold in applicable periods, and we calculate non-GAAP Gross Margin as non-GAAP Gross Profit divided by total net sales.
32

•Voxtel inventory impairment—Represents costs related to the discontinuation of one of our product lines manufactured by Voxtel.
•Stock-based compensation—Represents non-cash expenses arising from the grant of stock-based awards. A significant portion of the cost included in fiscal year 2023 related to retirement of our former CEO.
•AMTC Facility consolidation one-time costs—Represents one-time costs incurred in connection with closing of the AMTC Facility and transitioning of test and assembly functions to the AMPI Facility announced in fiscal year 2020, consisting of: moving equipment between facilities, contract terminations and other non-recurring charges. The closure and transition of the AMTC Facility was substantially completed as of the end of March 2021, and we sold the AMTC Facility in August 2021.
•Amortization of acquisition-related intangible assets—Represents non-cash expenses associated with the amortization of intangible assets in connection with the acquisition of Voxtel, which closed in August 2020.
•COVID-19 related expenses—Represents expenses attributable to the COVID-19 pandemic primarily related to increased purchases of masks, gloves and other protective materials, and overtime premium compensation paid for maintaining 24-hour service at the AMPI Facility through fiscal year 2022.
Non-GAAP Operating Expenses, non-GAAP Operating Income and non-GAAP Operating Margin
We calculate non-GAAP Operating Expenses and non-GAAP Operating Income excluding the same items excluded above to the extent they are classified as operating expenses, and also excluding the items below in applicable periods. We calculate non-GAAP Operating Margin as non-GAAP Operating Income divided by total net sales.
•Transaction fees—Represents transaction-related legal and consulting fees incurred primarily in connection with (i) one-time transaction-related legal, consulting and registration fees related to a secondary offering on behalf of certain stockh olders in fiscal 2022 and (ii) one-time transaction-related legal and consulting fees in fiscal 2023 and 2022 not related to (i).
•Severance—Represents (i) severance costs associated with the closing of the AMTC Facility and the transitioning of test and assembly functions to the AMPI Facility announced and initiated in fiscal year 2020, (ii) severance costs related to the discontinuation of one of our product lines manufactured by Voxtel in fiscal year 2022, and (iii) nonrecurring separation costs related to the departures of executive officers in fiscal years 2023 and 2022.
•Change in fair value of contingent consideration—Represents the change in fair value of contingent consideration payable in connection with the acquisition of Voxtel.
EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin
We calculate EBITDA as net income minus interest income (expense), tax provision (benefit), and depreciation and amortization expenses. We calculate Adjusted EBITDA as EBITDA excluding the same items excluded above and also excluding the items below in applicable periods. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total net sales.
•Non-core (gain) loss on sale of equipment—Represents non-core miscellaneous losses and gains on the sale of equipment.
•Foreign currency translation (gain) loss—Represents losses and gains resulting from the remeasurement and settlement of intercompany debt and operational transactions, as well as transactions with external customers or vendors denominated in currencies other than the functional currency of the legal entity in which the transaction is recorded.
•(Loss) income in earnings of equity investment—Represents our equity method investment in PSL.
•Unrealized loss on investments—Represents mark-to-market adjustments on equity investments with readily determinable fair values.
Non-GAAP Profit before Tax, Non-GAAP Net Income, and Non-GAAP Basic and Diluted Earnings Per Share
We calculate non-GAAP Profit before Tax as Income before Income Taxes excluding the same items excluded above. We calculate non-GAAP Net Income as Net Income excluding the same items excluded above and also excluding the item below in applicable periods.
33

Non-GAAP Provision for Income Tax
In calculating non-GAAP Provision for Income Tax, we have added back the following to GAAP Income Tax Provision:
•Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit Before Tax described above and elimination of discrete tax adjustments.

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Gross Profit |  |  |  |  |  |  |  |  |  |
GAAP Gross Profit |  | $ | 118,374 |  | $ | 109,603 |  | $ | 94,160 |  |  |  |
Voxtel inventory impairment |  | — |  | — |  | 2,835 |  |  |  |
Stock-based compensation |  | 832 |  | 1,184 |  | 528 |  |  |  |
AMTC Facility consolidation one-time costs |  | — |  | — |  | 137 |  |  |  |
Amortization of acquisition-related intangible assets |  | 273 |  | 273 |  | 273 |  |  |  |
COVID-19 related expenses |  | — |  | 296 |  | 343 |  |  |  |
Total Non-GAAP Adjustments |  | $ | 1,105 |  | $ | 1,753 |  | $ | 4,116 |  |  |  |
Non-GAAP Gross Profit |  | $ | 119,479 |  | $ | 111,356 |  | $ | 98,276 |  |  |  |
Non-GAAP Gross Margin |  | 54.9% |  | 55.6% |  | 52.2% |  |  |  |

34

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Operating Expenses |  |  |  |  |  |  |  |  |  |
GAAP Operating Expenses |  | $ | 103,637 |  |  | $ | 79,354 |  |  | $ | 61,918 |  |  |  |  |
Research and Development Expenses |  |  |  |  |  |  |  |  |  |
GAAP Research and Development Expenses |  | 33,857 |  |  | 32,432 |  |  | 29,554 |  |  |  |  |
Stock-based compensation |  | 1,128 |  |  | 1,119 |  |  | 752 |  |  |  |  |
AMTC Facility consolidation one-time costs |  | — |  |  | — |  |  | 2 |  |  |  |  |
COVID-19 related expenses |  | — |  |  | 3 |  |  | 6 |  |  |  |  |
Transaction fees |  | 202 |  |  | 5 |  |  | — |  |  |  |  |
Non-GAAP Research and Development Expenses |  | 32,527 |  |  | 31,305 |  |  | 28,794 |  |  |  |  |
Selling, General and Administrative Expenses |  |  |  |  |  |  |  |  |  |
GAAP Selling, General and Administrative Expenses |  | 69,980 |  |  | 46,822 |  |  | 32,064 |  |  |  |  |
Stock-based compensation |  | 32,176 |  |  | 12,598 |  |  | 3,551 |  |  |  |  |
AMTC Facility consolidation one-time costs |  | 96 |  |  | 74 |  |  | 324 |  |  |  |  |
Amortization of acquisition-related intangible assets |  | 22 |  |  | 22 |  |  | 29 |  |  |  |  |
COVID-19 related expenses |  | — |  |  | 215 |  |  | 381 |  |  |  |  |
Transaction fees |  | 1,597 |  |  | 384 |  |  | 23 |  |  |  |  |
Severance |  | 4,186 |  |  | — |  |  | 168 |  |  |  |  |
Non-GAAP Selling, General and Administrative Expenses |  | 31,903 |  |  | 33,529 |  |  | 27,588 |  |  |  |  |
Change in fair value of contingent consideration |  | (200) |  |  | 100 |  |  | 300 |  |  |  |  |
Total Non-GAAP Adjustments |  | 39,207 |  |  | 14,520 |  |  | 5,536 |  |  |  |  |
Non-GAAP Operating Expenses |  | $ | 64,430 |  |  | $ | 64,834 |  |  | $ | 56,382 |  |  |  |  |

35

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Operating Income |  |  |  |  |  |  |  |  |  |
GAAP Operating Income |  | $ | 14,737 |  | $ | 30,249 |  | $ | 32,242 |  |  |  |
Voxtel inventory impairment |  | — |  | — |  | 2,835 |  |  |  |
Stock-based compensation |  | 34,136 |  | 14,901 |  | 4,831 |  |  |  |
AMTC Facility consolidation one-time costs |  | 96 |  | 74 |  | 463 |  |  |  |
Amortization of acquisition-related intangible assets |  | 295 |  | 295 |  | 302 |  |  |  |
COVID-19 related expenses |  | — |  | 514 |  | 730 |  |  |  |
Change in fair value of contingent consideration |  | (200) |  | 100 |  | 300 |  |  |  |
Transaction fees |  | 1,799 |  | 389 |  | 23 |  |  |  |
Severance |  | 4,186 |  | — |  | 168 |  |  |  |
Total Non-GAAP Adjustments |  | $ | 40,312 |  | $ | 16,273 |  | $ | 9,652 |  |  |  |
Non-GAAP Operating Income |  | $ | 55,049 |  | $ | 46,522 |  | $ | 41,894 |  |  |  |
Non-GAAP Operating Margin (% of net sales) |  | 25.3% |  | 23.2% |  | 22.3% |  |  |  |

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of EBITDA and Adjusted EBITDA |  |  |  |  |  |  |  |  |  |
GAAP Net Income |  | $ | 10,283 |  | $ | 25,652 |  | $ | 27,707 |  |  |  |
Interest expense (income), net |  | 120 |  | (707) |  | 345 |  |  |  |
Income tax provision |  | 1,965 |  | 4,504 |  | 4,263 |  |  |  |
Depreciation & amortization |  | 11,918 |  | 12,006 |  | 12,172 |  |  |  |
EBITDA |  | $ | 24,286 |  | $ | 41,455 |  | $ | 44,487 |  |  |  |
Non-core (gain) loss on sale of equipment |  | (3) |  | 1 |  | (35) |  |  |  |
Voxtel inventory impairment |  | — |  | — |  | 2,835 |  |  |  |
Foreign currency translation (gain) loss |  | (1,924) |  | 513 |  | 254 |  |  |  |
Loss (income) in earnings of equity investment |  | 864 |  | (215) |  | (279) |  |  |  |
Unrealized loss on investments |  | 3,486 |  | 760 |  | — |  |  |  |
Stock-based compensation |  | 34,136 |  | 14,901 |  | 4,831 |  |  |  |
AMTC Facility consolidation one-time costs |  | 96 |  | 74 |  | 463 |  |  |  |
COVID-19 related expenses |  | — |  | 514 |  | 730 |  |  |  |
Change in fair value of contingent consideration |  | (200) |  | 100 |  | 300 |  |  |  |
Transaction fees |  | 1,799 |  | 389 |  | 23 |  |  |  |
Severance |  | 4,186 |  | — |  | 168 |  |  |  |
Adjusted EBITDA |  | $ | 66,726 |  | $ | 58,492 |  | $ | 53,777 |  |  |  |
Adjusted EBITDA Margin (% of net sales) |  | 30.6% |  | 29.2% |  | 28.6% |  |  |  |

36

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Profit before Tax |  |  |  |  |  |  |  |  |  |
GAAP Income before Tax Provision |  | $ | 12,248 |  |  | $ | 30,156 |  |  | $ | 31,970 |  |  |  |  |
Non-core (gain) loss on sale of equipment |  | (3) |  |  | 1 |  |  | (35) |  |  |  |  |
Voxtel inventory impairment |  | — |  |  | — |  |  | 2,835 |  |  |  |  |
Foreign currency translation (gain) loss |  | (1,924) |  |  | 513 |  |  | 254 |  |  |  |  |
Loss (income) in earnings of equity investment |  | 864 |  |  | (215) |  |  | (279) |  |  |  |  |
Unrealized loss on investments |  | 3,486 |  |  | 760 |  |  | — |  |  |  |  |
Stock-based compensation |  | 34,136 |  |  | 14,901 |  |  | 4,831 |  |  |  |  |
AMTC Facility consolidation one-time costs |  | 96 |  |  | 74 |  |  | 463 |  |  |  |  |
Amortization of acquisition-related intangible assets |  | 295 |  |  | 295 |  |  | 302 |  |  |  |  |
COVID-19 related expenses |  | — |  |  | 514 |  |  | 730 |  |  |  |  |
Change in fair value of contingent consideration |  | (200) |  |  | 100 |  |  | 300 |  |  |  |  |
Transaction fees |  | 1,799 |  |  | 389 |  |  | 23 |  |  |  |  |
Severance |  | 4,186 |  |  | — |  |  | 168 |  |  |  |  |
Total Non-GAAP Adjustments |  | $ | 42,735 |  |  | $ | 17,332 |  |  | $ | 9,592 |  |  |  |  |
Non-GAAP Profit before Tax |  | $ | 54,983 |  |  | $ | 47,488 |  |  | $ | 41,562 |  |  |  |  |

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Provision for Income Taxes |  |  |  |  |  |  |  |  |  |
GAAP Income Tax Provision |  | $ | 1,965 |  | $ | 4,504 |  | $ | 4,263 |  |  |  |
GAAP effective tax rate |  | 16.0% |  | 14.9% |  | 13.3% |  |  |  |
Tax effect of adjustments to GAAP results |  | 5,900 |  | 2,817 |  | 2,091 |  |  |  |
Non-GAAP Provision for Income Taxes |  | $ | 7,865 |  | $ | 7,321 |  | $ | 6,354 |  |  |  |
Non-GAAP effective tax rate |  | 14.3% |  | 15.4% |  | 15.3% |  |  |  |

37

|  | Three-Month Period Ended |  |
|  | June 24, 2022 |  | March 25, 2022 |  | June 25, 2021 |  |  |  |
|  | (Dollars in thousands)
Reconciliation of Non-GAAP Net Income |  |  |  |  |  |  |  |  |  |
GAAP Net Income |  | $ | 10,283 |  |  | $ | 25,652 |  |  | $ | 27,707 |  |  |  |  |
GAAP Basic Earnings per Share |  | $ | 0.05 |  |  | $ | 0.14 |  |  | $ | 0.15 |  |  |  |  |
GAAP Diluted Earnings per Share |  | $ | 0.05 |  |  | $ | 0.13 |  |  | $ | 0.14 |  |  |  |  |
Non-core (gain) loss on sale of equipment |  | (3) |  |  | 1 |  |  | (35) |  |  |  |  |
Voxtel inventory impairment |  | — |  |  | — |  |  | 2,835 |  |  |  |  |
Foreign currency translation (gain) loss |  | (1,924) |  |  | 513 |  |  | 254 |  |  |  |  |
Loss (income) in earnings of equity investment |  | 864 |  |  | (215) |  |  | (279) |  |  |  |  |
Unrealized loss on investments |  | 3,486 |  |  | 760 |  |  | — |  |  |  |  |
Stock-based compensation |  | 34,136 |  |  | 14,901 |  |  | 4,831 |  |  |  |  |
AMTC Facility consolidation one-time costs |  | 96 |  |  | 74 |  |  | 463 |  |  |  |  |
Amortization of acquisition-related intangible assets |  | 295 |  |  | 295 |  |  | 302 |  |  |  |  |
COVID-19 related expenses |  | — |  |  | 514 |  |  | 730 |  |  |  |  |
Change in fair value of contingent consideration |  | (200) |  |  | 100 |  |  | 300 |  |  |  |  |
Transaction fees |  | 1,799 |  |  | 389 |  |  | 23 |  |  |  |  |
Severance |  | 4,186 |  |  | — |  |  | 168 |  |  |  |  |
Tax effect of adjustments to GAAP results |  | (5,900) |  |  | (2,817) |  |  | (2,091) |  |  |  |  |
Non-GAAP Net Income |  | $ | 47,118 |  |  | $ | 40,167 |  |  | $ | 35,208 |  |  |  |  |
Basic weighted average common shares |  | 190,638,135 |  |  | 189,997,738 |  |  | 189,585,381 |  |  |  |  |
Diluted weighted average common shares |  | 192,406,276 |  |  | 192,125,252 |  |  | 191,163,074 |  |  |  |  |
Non-GAAP Basic Earnings per Share |  | $ | 0.25 |  |  | $ | 0.21 |  |  | $ | 0.19 |  |  |  |  |
Non-GAAP Diluted Earnings per Share |  | $ | 0.24 |  |  | $ | 0.21 |  |  | $ | 0.18 |  |  |  |  |

Liquidity and Capital Resources
As of June 24, 2022, we had $286.6 million of cash and cash equivalents and $417.2 million of working capital compared to $282.4 million of cash and cash equivalents and $407.5 million of working capital as of March 25, 2022. Working capital is impacted by the timing and extent of our business needs.
Our primary requirements for liquidity and capital are working capital, capital expenditures, principal and interest payments on our outstanding debt and other general corporate needs. Historically, these cash requirements have been met through cash provided by operating activities and cash and cash equivalents. Our current capital deployment strategy for 2023 is to invest excess cash on hand to support our continued growth initiatives into select markets, planned capital expenditures and strategic arrangements, as well as consider potential acquisitions. As of June 24, 2022, the Company is not party to any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures, or capital resources. The cash requirements for the upcoming fiscal year relate to our operating leases, operating and capital purchase commitments and expected contributions to our defined benefit and contribution plans. For information regarding the Company’s expected cash requirements and timing of payments related to leases and noncancellable purchase commitments, see Note 17, “Commitments and Contingencies” to the Company’s 2022 Annual Report. Additionally, refer to Note 16, “Retirement Plans” to the Company’s 2022 Annual Report for more information related to the Company’s pension and defined contribution plans.
38

We believe that our existing cash will be sufficient to finance our continued operations, growth strategy, planned capital expenditures and the additional expenses that we expect to incur during the next 12 months. In order to support and achieve our future growth plans, we may need or seek advantageously to obtain additional funding through equity or debt financing. We believe that our current operating structure will facilitate sufficient cash flows from operations to satisfy our expected long-term liquidity requirements beyond the next 12 months. If these resources are not sufficient to satisfy our liquidity requirements due to changes in circumstances, we may be required to seek additional financing. If we raise additional funds by issuing equity securities, our stockholders will experience dilution. Debt financing, if available, may contain covenants that significantly restrict our operations or our ability to obtain additional debt financing in the future. Any additional financing that we raise may contain terms that are not favorable to us or our stockholders. We cannot assure you that we would be able to obtain additional financing on terms favorable to us or our existing stockholders, or at all.
Cash Flows from Operating, Investing and Financing Activities
The following table summarizes our cash flows for the three months ended June 24, 2022 and June 25, 2021:

| Three-Month Period Ended
| June 24, 2022 |  | June 25, 2021
| (dollars in thousands)
Net cash provided by operating activities | $ | 36,553 |  |  | $ | 38,495 |
Net cash used in investing activities | (14,389) |  |  | (15,346) |
Net cash used in financing activities | (9,137) |  |  | — |
Effect of exchange rate changes on cash and cash equivalents | (6,554) |  |  | 2,608 |
Net increase in cash and cash equivalents and restricted cash | $ | 6,473 |  |  | $ | 25,757 |

Operating Activities
Net cash provided by operating activities was $36.6 million in the three months ended June 24, 2022, resulting primarily from our net income of $10.3 million and noncash charges of $44.2 million, partially offset by a net decrease in operating assets and liabilities of $17.9 million. Net changes in operating assets and liabilities consisted of a $13.1 million increase in prepaid expenses, a $4.9 million increase in inventories, a $4.7 million increase in trade accounts receivable, net, and a $3.3 million decrease in net amounts due from related parties, partially offset by a $1.2 million increase in accrued expenses and other current and long-term liabilities, a $4.1 million increase in trade accounts payable and a $2.7 million decrease in other accounts receivable. The increase in prepaid expenses and other assets was primarily due to higher long-term deposits and the timing of tax payments, including value-added taxes receivable, insurance and contract costs. The increase in inventories was primarily the result of inventory builds to support anticipated sales growth in fiscal 2023. The increase in trade accounts receivable, net was primarily a result of increased sales year-over-year, as well as the timing of receipts from customers. The decrease in net amounts due to related parties was primarily due to variations in the timing of such payments in the ordinary course of business. The increase in accrued expenses and other current and long-term liabilities was primarily the result of higher accrued income taxes and accrued personnel costs, partially offset by higher management incentive payments. Accounts payable increased mainly due to the timing of payments to suppliers and vendors, partially offset by higher operating purchases, including unpaid capital expenditures of $2.6 million. The decrease in accounts receivable - other was primarily due to increased distributor sales year-over-year, as well as the timing of receipts from Sanken.
Net cash provided by operating activities was $38.5 million in the three months ended June 25, 2021, resulting primarily from our net income of $27.7 million and noncash charges of $17.5 million, partially offset by a net decrease in operating assets and liabilities of $6.7 million. Net changes in operating assets and liabilities consisted of a $10.0 million increase in trade accounts receivable, net, a $2.4 million decrease in accrued expenses and other current and long-term liabilities and a $3.0 million decrease in trade accounts payable, partially offset by a $5.1 million decrease in inventories, a $1.7 million decrease in prepaid expenses, and a $1.9 million increase in net amounts due from related parties. The increase in trade accounts receivable, net was primarily a result of increased sales year-over-year, as well as the timing of receipts from customers. The decrease in accrued expenses and other current and long-term liabilities was primarily the result of management incentive payments, partially offset by higher accrued personnel costs. Accounts payable decreased mainly due to the timing of payments to suppliers and vendors, partially offset by higher operating purchases, including unpaid capital expenditures of $5.5 million. The decrease in inventories was primarily a result of the continued drawdown after building inventory up in prior periods to support anticipated sales growth and recovery from the COVID-19 pandemic. The decrease in prepaid expenses and other assets was primarily due to the timing of tax payments, including value-added taxes receivable,
39

insurance and contract costs. The increase in net amounts due to related parties was primarily due to variations in the timing of such payments in the ordinary course of business.
Investing Activities
Net cash used in investing activities primarily consists of purchases of property, plant and equipment, partially offset by proceeds from sales of property, plant and equipment.
Net cash used in investing activities was $14.4 million in the three months ended June 24, 2022, consisting of purchases of property, plant and equipment.
Net cash used in investing activities was $15.3 million in the three months ended June 25, 2021, consisting of purchases of property, plant and equipment.
Financing Activities
Net cash used in financing activities was $9.1 million in the three months ended June 24, 2022, consisting of taxes related to the net settlement of equity awards, partially offset by proceeds received related to the quarterly payment from PSL on our related party loan.
There was no net cash used in financing activities in the three months ended June 25, 2021.
Debt Obligations
On September 30, 2020, we entered into a term loan credit agreement with Credit Suisse AG, Cayman Islands Branch, as administrative agent and collateral agent, and the other agents, arrangers and lenders party thereto, providing for a $325.0 million senior secured term loan facility due in 2027 (the “Term Loan Facility”). On September 30, 2020, we also entered into a revolving facility credit agreement with Mizuho Bank, Ltd., as administrative agent and collateral agent, and the other agents, arrangers and lenders party thereto, providing for a $50.0 million senior secured revolving credit facility expiring in 2023 (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facilities”). As of June 24, 2022, we had $25.0 million in aggregate principal amount of debt outstanding under our Senior Secured Credit Facilities. There were no material changes in our debt obligations from those disclosed in our 2022 Annual Report.
AMPI Credit Facilities
Refer to Note 10, “Debt and Other Borrowings” for information regarding the line of credit agreements in our Philippine location.
Recent Accounting Pronouncements
See Note 2, “Summary of Significant Accounting Policies” in the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report for a full description of recent accounting pronouncements, including the respective dates of adoption or expected adoption and effects on our condensed consolidated financial statements contained in Item 1 of this Quarterly Report.
Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures of contingencies at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Our significant accounting policies are described in Note 2, “Summary of Significant Accounting Policies” to our consolidated financial statements included in our 2022 Annual Report. There have been no material changes in our critical accounting policies and estimates since March 25, 2022.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
There have been no material changes in our exposures to market risk since March 25, 2022. For details on the Company’s interest rate, foreign currency exchange, and inflation risks, see “Part I, Item 7A. “Quantitative and Qualitative Information About Market Risks” in our 2022 Annual Report.
40

Item 4. Controls and Procedures.
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures as of June 24, 2022. Based on the evaluation of our disclosure controls and procedures as of June 24, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15(d)-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
41

PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
From time to time, we may be involved in claims and proceedings arising in the ordinary course of our business. The outcome of any such claims or proceedings, regardless of the merits, is inherently uncertain. We are not currently party to any material legal proceedings, and we are not aware of any pending or threatened legal proceeding against us that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.
Item 1A. Risk Factors.
The information presented below updates, and should be read in conjunction with, the risk factors in Part I, Item 1A. “Risk Factors” in the Company’s 2022 Annual Report. Except as presented below. There were no other significant changes in the Company’s risk factors during the quarter ended June 24, 2022.
Sustained inflation could have a material adverse effect on our business, financial condition, results of operations and liquidity.
Inflation rates in the markets in which we operate have increased and may continue to rise. Inflation over the last several months has led us to experience higher costs, including higher labor costs, wafer and other costs for materials from suppliers, and transportation costs. Our suppliers have raised their prices and may continue to raise prices, and in the competitive markets in which we operate, we may not be able to make corresponding price increases to preserve our gross margins and profitability. If inflation rates continue to rise or remain elevated for a sustained period of time, they could have a material adverse effect on our business, financial condition, results of operations and liquidity.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
42

Item 6. Exhibits
(a) Exhibits

Exhibit No. |  | Description of Exhibit |  |  |  |  |  |  |  |  |  |
10.1 |  | Second Amended and Restated Severance Agreement, dated May 6, 2022, by and between Allegro MicroSystems, Inc. and Ravi Vig (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 9, 2022).* |  |  |  |  |  |  |  |  |  |
10.2 |  | Letter Agreement, dated May 6, 2022, between Allegro MicroSystems, Inc. and Ravi Vig (incorporated by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 9, 2022).* |  |  |  |  |  |  |  |  |  |
10.3 |  | Employment Agreement, dated May 2, 2022, by and between Allegro MicroSystems, Inc. and Vineet Nargolwala (incorporated by reference from Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on May 9, 2022).* |  |  |  |  |  |  |  |  |  |
10.4 |  | Separation Agreement and General Release, dated December 17, 2021, by and between Allegro MicroSystems, Inc. and Christopher Brown.* |  |  |  |  |  |  |  |  |  |
10.5 |  | Amended and Restated Stockholders Agreement of Allegro MicroSystems, Inc., dated as of June 16, 2022 (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 21, 2022). |  |  |  |  |  |  |  |  |  |
31.1 |  | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |  |  |
31.2 |  | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |  |  |
32.1 |  | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |  |  |
32.2 |  | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |  |  |
101.INS |  | Inline XBRL Instance Document. The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document. |  |  |  |  |  |  |  |  |  |
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document. |  |  |  |  |  |  |  |  |  |
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |  |  |  |  |  |  |  |  |  |
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document. |  |  |  |  |  |  |  |  |  |
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document. |  |  |  |  |  |  |  |  |  |
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |  |  |  |  |  |  |  |  |  |
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 filed herewith). |  |  |  |  |  |  |  |  |  |

* Indicates management contract or compensatory plan, contract or arrangement.
43

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | ALLEGRO MICROSYSTEMS, INC.
Date: August 1, 2022 |  | By: | /s/ Vineet Nargolwala
|  |  | Vineet Nargolwala
|  |  | President and Chief Executive Officer (principal executive officer)
Date: August 1, 2022 |  | By: | /s/ Derek P. D’Antilio
|  |  | Derek P. D’Antilio
|  |  | Senior Vice President, Chief Financial Officer and Treasurer (principal financial and accounting officer)

44